Cover
Cover - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Feb. 16, 2023 | Jun. 30, 2022 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-40806 | ||
Entity Registrant Name | Freshworks Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 33-1218825 | ||
Entity Address, Address Line One | 2950 S. Delaware Street | ||
Entity Address, Address Line Two | Suite 201 | ||
Entity Address, City or Town | San Mateo | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94403 | ||
City Area Code | 650 | ||
Local Phone Number | 513-0514 | ||
Title of 12(b) Security | Class A common stock, par value $0.00001 per share | ||
Trading Symbol | FRSH | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 1,520 | ||
Documents Incorporated by Reference | Portions of the registrant's definitive proxy statement for the 2023 Annual Meeting of Stockholders (the "2023 Proxy Statement") are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein. The 2023 Proxy Statement will be filed with Securities and Exchange Commission within 120 days of the registrant's fiscal year ended December 31, 2022. | ||
Entity Central Index Key | 0001544522 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Class A Common Stock | |||
Document Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 166,060,677 | ||
Class B Common Stock | |||
Document Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 124,172,260 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Auditor Information [Abstract] | |
Auditor Name | DELOITTE & TOUCHE LLP |
Auditor Location | San Jose, California |
Auditor Firm ID | 34 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 304,083 | $ 747,861 |
Marketable securities | 843,405 | 575,679 |
Accounts receivable, net of allowance of $6,628 and $6,030 | 70,470 | 51,756 |
Deferred contract acquisition costs | 20,139 | 14,640 |
Prepaid expenses and other current assets | 38,913 | 31,440 |
Total current assets | 1,277,010 | 1,421,376 |
Property and equipment, net | 24,139 | 21,478 |
Operating lease right-of-use assets | 33,024 | |
Deferred contract acquisition costs, noncurrent | 19,536 | 15,007 |
Intangible assets, net | 303 | 1,894 |
Goodwill | 6,181 | 6,181 |
Deferred tax assets | 8,689 | 6,284 |
Other assets | 11,334 | 10,592 |
Total assets | 1,380,216 | 1,482,812 |
Current liabilities: | ||
Accounts payable | 5,908 | 6,321 |
Accrued liabilities | 59,008 | 55,829 |
Deferred revenue | 205,626 | 160,173 |
Income tax payable | 1,150 | 1,023 |
Total current liabilities | 271,692 | 223,346 |
Operating lease liabilities, non-current | 28,174 | |
Other liabilities | 28,532 | 21,427 |
Total liabilities | 328,398 | 244,773 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity: | ||
Preferred stock, value | 0 | 0 |
Additional paid-in capital | 4,562,319 | 4,509,724 |
Accumulated other comprehensive loss | (7,431) | (747) |
Accumulated deficit | (3,503,073) | (3,270,941) |
Total stockholders' equity | 1,051,818 | 1,238,039 |
Total liabilities and stockholders' equity | 1,380,216 | 1,482,812 |
Class A Common Stock | ||
Stockholders' equity: | ||
Common stock, value | 2 | 0 |
Class B Common Stock | ||
Stockholders' equity: | ||
Common stock, value | $ 1 | $ 3 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Accounts receivable, allowance for credit loss, current | $ 6,628 | $ 6,030 |
Preferred stock, par value (in dollars per share) | $ 0.00001 | $ 0.00001 |
Preferred stock, authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Class A Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.00001 | $ 0.00001 |
Common stock, authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, issued (in shares) | 162,825,075 | 50,554,821 |
Common stock, outstanding (in shares) | 162,825,075 | 50,554,821 |
Class B Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.00001 | $ 0.00001 |
Common stock, authorized (in shares) | 350,000,000 | 350,000,000 |
Common stock, issued (in shares) | 126,268,150 | 222,789,562 |
Common stock, outstanding (in shares) | 126,268,150 | 222,789,562 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 497,999 | $ 371,022 | $ 249,659 |
Cost of revenue | 95,772 | 78,030 | 52,492 |
Gross profit | 402,227 | 292,992 | 197,167 |
Operating expense: | |||
Research and development | 135,543 | 120,407 | 69,210 |
Sales and marketing | 343,207 | 260,345 | 133,277 |
General and administrative | 156,849 | 117,022 | 50,792 |
Total operating expenses | 635,599 | 497,774 | 253,279 |
Loss from operations | (233,372) | (204,782) | (56,112) |
Interest and other income, net | 12,582 | 23,303 | 2,833 |
Loss before income taxes | (220,790) | (181,479) | (53,279) |
Provision for income taxes | 11,342 | 10,516 | 4,015 |
Net loss | (232,132) | (191,995) | (57,294) |
Accretion of redeemable convertible preferred stock | 0 | (2,646,662) | (1,560,524) |
Net loss attributable to common stockholders - basic and diluted | |||
Net loss attributable to common stockholders - basic | (232,132) | (2,838,657) | (1,617,818) |
Net loss attributable to common stockholders - diluted | $ (232,132) | $ (2,838,657) | $ (1,617,818) |
Net loss attributable to common stockholders - basic and diluted | |||
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share) | $ (0.82) | $ (21.73) | $ (21.03) |
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share) | $ (0.82) | $ (21.73) | $ (21.03) |
Weighted average shares used in computing net loss per share attributable to common stockholders - basic and diluted | |||
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares) | 284,587 | 130,652 | 76,945 |
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares) | 284,587 | 130,652 | 76,945 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | |||
Net loss | $ (232,132) | $ (191,995) | $ (57,294) |
Other comprehensive (loss) income: | |||
Unrealized (loss) gain on marketable securities | (6,684) | (1,158) | 272 |
Comprehensive loss | $ (238,816) | $ (193,153) | $ (57,022) |
CONSOLIDATED STATEMENTS OF REDE
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income | Accumulated Deficit |
Beginning balance (in shares) at Dec. 31, 2019 | 153,938,000 | ||||
Beginning balance at Dec. 31, 2019 | $ 1,334,572 | ||||
Redeemable Convertible Preferred Stock | |||||
Accretion of redeemable convertible preferred stock | $ 1,560,524 | ||||
Ending balance (in shares) at Dec. 31, 2020 | 153,938,000 | ||||
Ending balance at Dec. 31, 2020 | $ 2,895,096 | ||||
Beginning balance (in shares) at Dec. 31, 2019 | 76,821,000 | ||||
Beginning balance at Dec. 31, 2019 | (1,122,721) | $ 1 | $ 0 | $ 139 | $ (1,122,861) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Accretion of redeemable convertible preferred stock | (1,560,524) | (43,526) | (1,516,998) | ||
Issuance of common stock upon exercise of stock options (in shares) | 798,000 | ||||
Issuance of common stock upon exercise of stock options | 246 | 246 | |||
Stock-based compensation | 43,280 | 43,280 | |||
Unrealized (loss) gain on marketable securities | 272 | 272 | |||
Net loss | (57,294) | (57,294) | |||
Ending balance (in shares) at Dec. 31, 2020 | 77,619,000 | ||||
Ending balance at Dec. 31, 2020 | (2,696,741) | $ 1 | 0 | 411 | (2,697,153) |
Redeemable Convertible Preferred Stock | |||||
Accretion of redeemable convertible preferred stock | $ 2,646,662 | ||||
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) | (153,938,000) | ||||
Conversion of redeemable convertible preferred stock into common stock upon initial public offering | $ (5,541,758) | ||||
Ending balance (in shares) at Dec. 31, 2021 | 0 | ||||
Ending balance at Dec. 31, 2021 | $ 0 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Accretion of redeemable convertible preferred stock | (2,646,662) | (2,264,869) | (381,793) | ||
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) | 153,938,000 | ||||
Conversion of redeemable convertible preferred stock into common stock upon initial public offering | 5,541,758 | $ 2 | 5,541,756 | ||
Issuance of common stock upon initial public offering, net of underwriting discount and offering expenses (in shares) | 31,350,000 | ||||
Issuance of common stock upon initial public offering, net of underwriting discount and offering expenses | 1,062,058 | 1,062,058 | |||
Issuance of common stock upon exercise of stock options (in shares) | 537,000 | ||||
Issuance of common stock upon exercise of stock options | 94 | 94 | |||
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for tax purposes (in shares) | 9,850,000 | ||||
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for tax purposes | $ (3,343) | (3,343) | |||
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes (in shares) | 0 | ||||
Stock-based compensation | $ 174,028 | 174,028 | |||
Unrealized (loss) gain on marketable securities | (1,158) | (1,158) | |||
Net loss | (191,995) | (191,995) | |||
Ending balance (in shares) at Dec. 31, 2021 | 273,294,000 | ||||
Ending balance at Dec. 31, 2021 | $ 1,238,039 | $ 3 | 4,509,724 | (747) | (3,270,941) |
Ending balance (in shares) at Dec. 31, 2022 | 0 | ||||
Ending balance at Dec. 31, 2022 | $ 0 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock upon exercise of stock options (in shares) | 406,000 | 407,000 | |||
Issuance of common stock upon exercise of stock options | $ 109 | 109 | |||
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for tax purposes (in shares) | 14,570,000 | ||||
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for tax purposes | $ (167,745) | (167,745) | |||
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes (in shares) | 822,423 | 822,000 | |||
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes | $ 10,870 | 10,870 | |||
Stock-based compensation | 209,361 | 209,361 | |||
Unrealized (loss) gain on marketable securities | (6,684) | (6,684) | |||
Net loss | (232,132) | (232,132) | |||
Ending balance (in shares) at Dec. 31, 2022 | 289,093,000 | ||||
Ending balance at Dec. 31, 2022 | $ 1,051,818 | $ 3 | $ 4,562,319 | $ (7,431) | $ (3,503,073) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash Flows Operating Activities: | |||
Net loss | $ (232,132) | $ (191,995) | $ (57,294) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
Depreciation and amortization | 11,504 | 13,294 | 11,169 |
Amortization of deferred contract acquisition costs | 18,532 | 12,844 | 7,681 |
Non-cash lease expense | 6,195 | ||
Stock-based compensation | 207,696 | 173,443 | 43,280 |
Premium (discount) amortization on marketable securities | (1,627) | 1,757 | 1,227 |
Gain realized on sale of marketable securities and non-marketable equity investments | 0 | (23,836) | (132) |
Change in fair value of equity securities | (71) | (132) | (107) |
Deferred income taxes | (2,405) | (1,907) | (2,360) |
Other | 887 | (28) | 143 |
Changes in operating assets and liabilities: | |||
Accounts receivable | (18,892) | (17,509) | (9,932) |
Deferred contract acquisition costs | (28,560) | (24,218) | (14,344) |
Prepaid expenses and other assets | (8,141) | (5,942) | (8,165) |
Accounts payable | 77 | 1,986 | 53 |
Accrued and other liabilities | 7,746 | 17,714 | 24,867 |
Deferred revenue | 45,453 | 55,989 | 36,444 |
Operating lease liabilities | (8,787) | ||
Net cash provided by (used in) operating activities | (2,525) | 11,460 | 32,530 |
Cash Flows from Investing Activities: | |||
Purchases of property and equipment | (7,129) | (5,565) | (4,383) |
Proceeds from sale of property and equipment | 137 | 620 | 0 |
Capitalized internal-use software | (5,116) | (3,552) | (4,631) |
Sale of non-marketable equity investment | 0 | 23,979 | 0 |
Purchases of marketable securities | (848,560) | (686,078) | (115,689) |
Sales of marketable securities | 92,786 | 131,170 | 18,658 |
Maturities and redemptions of marketable securities | 483,055 | 119,130 | 101,445 |
Acquired intangible assets | 0 | 0 | (1,750) |
Business combination, net of cash acquired | 0 | 0 | (5,075) |
Net cash used in investing activities | (284,827) | (420,296) | (11,425) |
Cash Flows from Financing Activities: | |||
Proceeds from initial public offering, net of underwriting discounts | 0 | 1,069,348 | 0 |
Proceeds from issuance of common stock under employee stock purchase plan, net | 10,870 | 0 | 0 |
Proceeds from exercise of stock options | 109 | 94 | 246 |
Payment of withholding taxes on net share settlement of equity awards | (167,224) | (3,343) | 0 |
Payment of deferred offering costs | (109) | (6,830) | 0 |
Payment of acquisition-related liabilities | 0 | (900) | (2,155) |
Net cash provided by (used in) financing activities | (156,354) | 1,058,369 | (1,909) |
Net increase (decrease) in cash, cash equivalents and restricted cash | (443,706) | 649,533 | 19,196 |
Cash, cash equivalents and restricted cash, beginning of period | 747,864 | 98,331 | 79,135 |
Cash, cash equivalents and restricted cash, end of period | 304,158 | 747,864 | 98,331 |
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets: | |||
Cash and cash equivalents | 304,083 | 747,861 | 95,382 |
Restricted cash included in prepaid expenses and other current assets | 3 | 0 | 1,930 |
Restricted cash included in other assets | 72 | 3 | 1,019 |
Total cash, cash equivalents and restricted cash | 304,158 | 747,864 | 98,331 |
Supplemental cash flow information: | |||
Cash paid for taxes | 13,412 | 10,458 | 5,075 |
Non-cash investing and financing activities: | |||
Operating lease right-of-use assets obtained in exchange for operating lease obligations | 14,903 | ||
Stock-based compensation capitalized as internal-use software | 1,665 | 585 | 0 |
Accretion of redeemable convertible preferred stock | 0 | 2,646,662 | 1,560,524 |
Conversion of redeemable convertible preferred stock into common stock upon initial public offering | $ 0 | $ 5,541,758 | $ 0 |
Description of Business
Description of Business | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business | Description of Business Freshworks Inc. (Freshworks or the Company) is a software development company that provides modern software-as-a-service (SaaS) products that are designed with the user in mind. The Company was incorporated in Delaware in 2010 and is headquartered in San Mateo, California, and has foreign subsidiaries located in India, Australia, the United Kingdom, Ireland, Germany, France, the Netherlands, and Singapore. Initial Public Offering In September 2021, the Company completed its initial public offering (IPO), in which it issued and sold 31,350,000 shares of its newly authorized Class A common stock at $36.00 per share, which included 2,850,000 shares issued upon the exercise of the underwriters’ option to purchase additional shares. The Company received proceeds of approximately $1.1 billion from the IPO, net of underwriters’ discounts and offering expenses. As of December 31, 2021, deferred offering costs totaling $7.3 million were reclassified to stockholders' equity (deficit) as a reduction of the net proceeds from the IPO. Upon completion of the IPO, certain shares of Class B common stock then outstanding (excluding shares of Class B common stock issued upon conversion and reclassification of the redeemable convertible preferred stock described below) were automatically converted to Class A common stock on a one-to-one basis, unless an option to remain as Class B common stock was elected by the holder. In addition, all shares of redeemable convertible preferred stock then outstanding were converted into 153,937,730 shares of common stock on a one-to-one basis and then reclassified into Class B common stock. As detailed in Note 10— Stockholders' Equity and Stock-Based Compensation , under the 2011 Stock Plan, the Company granted employees restricted stock units (RSUs) with both a service and a liquidity performance condition. Upon the Company's IPO in September 2021, the liquidity event condition was met for all RSUs and the Company began to recognize stock-based compensation expense. RSUs that had already met the service condition at that date were entitled to one share of Class B common stock for each vested RSU. Stock Split In September 2021, the Company completed a 10-for-one forward stock split of the Company’s authorized, issued and outstanding stock. All share and per share information included in the accompanying consolidated financial statements and notes thereto has been adjusted on a retrospective basis to reflect this stock split. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. Foreign Currency Remeasurement and Transactions The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. Accordingly, each foreign subsidiary remeasures monetary assets and liabilities at period-end exchange rates, while non-monetary items are remeasured at historical rates. Revenues and expenses are remeasured at the exchange rates in effect on the day the transaction occurred, except for those expenses related to non-monetary assets and liabilities, which are remeasured at historical exchange rates. Remeasurement adjustments are recognized in interest and other income, net in the consolidated statements of operations, and have not been material for the years ended December 31, 2022, 2021, and 2020. Use of Estimates The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of acquired intangible assets and goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan and other compensation liabilities; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases. Segment Information The Company operates in a single operating segment. The Chief Executive Officer (CEO) is the chief operating decision maker of the Company and makes operating decisions, assesses financial performance, and allocates resources based upon discrete financial information at a consolidated level. Revenue Recognition The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes. The Company sells subscriptions to third-party resellers. The price at which subscriptions are sold to the reseller is typically discounted, as compared to the price at which the Company would sell to an end customer, in order to enable the reseller to realize a margin on the eventual sale to the end customer. As pricing to the reseller is fixed, and the Company lacks visibility into the pricing provided by the reseller to the end customer, reseller revenue is recorded net of any reseller discounts. Subscription Revenue Subscription revenue is primarily comprised of fees paid by the Company’s customers for accessing its cloud-based software during the term of the arrangement. Cloud-based services allow customers to use the Company’s multi-tenant software without requiring them to take possession of the software. Given that access to the cloud-based software represents a series of distinct services that comprise a single performance obligation that is satisfied over time, subscription revenue is recognized ratably over the contract term beginning on the commencement date of each contract, which is the date that the cloud-based software is made available to customers. Professional Services Revenue Professional services revenue is comprised of fees charged for services ranging from product configuration, data migration, systems integration, and training. The Company recognizes professional services revenues as services are performed. Customers with Multiple Performance Obligations Some of the Company’s contracts with customers contain both subscriptions and professional services. For these contracts, the Company accounts for individual performance obligations separately. The transaction price is allocated to the separate performance obligations on the basis of relative standalone selling price (SSP). The Company determines SSP by taking into consideration historical selling price of these performance obligations in similar transactions, as well as current pricing practices and other observable inputs including, but not limited to, customer size and geography. As the Company’s go-to-market strategies evolve, it may modify its pricing practices in the future, which could result in changes to SSP. Cost of Revenue Cost of revenue consists primarily of personnel-related expenses (primarily including salaries, related benefits, and stock-based compensation) for employees associated with the Company’s cloud-based infrastructure, payment gateway fees, voice, product support, and professional service organizations, as well as costs incurred by the Company for third-party hosting capabilities. Cost of revenue also includes third-party license fees, amortization of acquired intangibles, amortization of capitalized internal-use software, and allocation of general overhead expenses such as facilities and information technology. Research and Development Research and development costs are expensed as incurred and consist primarily of personnel-related expenses (primarily including salaries, related benefits, and stock-based compensation) for the Company’s product development employees. Research and development expenses also include non-personnel-related expenses such as third-party services for product development and consulting expenses, depreciation expense related to equipment used in research and development activities, and allocation of the Company’s general overhead expenses. Advertising Costs Advertising costs are charged to sales and marketing expense in the consolidated statements of operations as incurred. The Company recognized $47.2 million, $41.2 million, and $31.1 million for the years ended December 31, 2022, 2021, and 2020, respectively. Stock-Based Compensation The Company issues stock options and RSUs to employees, consultants and directors, and stock purchase rights granted under the 2021 Employee Stock Purchase Plan (ESPP) to employees based on the estimated fair value on the date of the grant. Stock-based compensation expense is recognized in the consolidated statements of operations on a straight-line basis over the requisite service period, which is the vesting period of the respective awards. Forfeitures are accounted for when they occur. The fair value of RSUs is based on the closing market price of its Class A common stock on the date of the grant. Prior to the IPO, the Company determined the fair value of the common stock underlying stock options and RSUs by considering numerous objective and subjective factors including, but not limited to: (i) independent third-party valuations, (ii) the prices, rights, preferences, and privileges of the Company’s redeemable convertible preferred stock relative to its common stock, (iii) the lack of marketability of the common stock, (iv) current business conditions and financial projections, and (iv) the likelihood of achieving an IPO or sale event. The fair values of stock options and the stock purchase rights under the ESPP are estimated using the Black-Scholes option-pricing model, which requires the input of highly subjective assumptions. These assumptions represent the Company's best estimates and involve inherent uncertainties and the application of the Company's judgement. The main assumptions used in the Black-Scholes option-pricing model include: Expected term— The expected term represents the period that stock-based awards are expected to be outstanding. The expected term for option grants is determined using the simplified method which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company considers this appropriate as there is not sufficient historical information available to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The expected term for ESPP is the length of time from the grant date to the date on which the stock is purchased by the employees. Stock price volatility— For the stock price volatility over the expected term of six months and one year, the Company estimates the stock price volatility using the combination of the average historical volatility of its own stock and those of comparable companies with similar characteristics to it. For expected term of greater than one year, since the Company's common stock lacks sufficient trading history, the stock price volatility over the expected term is estimated based on the average historical volatility of comparable companies with similar characteristics to those of the Company. Risk-free interest rate— The risk-free interest rate is based on the yield of the U.S. treasury debt securities commensurate with the expected term. Dividend yield— Since the Company has never paid and has no intention to pay cash dividends on its common stock, the dividend yield is zero. For the performance-based award granted to the CEO with both a service-based vesting condition and a market condition (as discussed further in Note 10— Stockholders' Equity and Stock-Based Compensation ), the Company determined the fair value of the award by using the Monte Carlo simulation model. The main assumptions used in the Monte Carlo simulation model include stock price volatility, risk-free interest rate, dividend yield and the measurement period, which is the period over which simulated stock prices of the Company are used to evaluate the possibility of achieving the specified stock price targets. Since both vesting conditions have to be met for each tranche of the award to ultimately vest, the associated stock-based compensation expense is recognized over the longer of the derived service period or the requisite service period, using the accelerated attribution method. Provided that the CEO remains employed by the Company in his current position, stock-based compensation expense is recognized over the requisite service period, regardless of whether the stock price goals are achieved. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December 31, 2022 and 2021, the Company has recorded a full valuation allowance against its U.S. deferred tax assets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is more likely than not of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. Cash and Cash Equivalents Cash and cash equivalents consist of deposits held at financial institutions, money market funds, as well as highly liquid investments with an original maturity of three months or less when purchased. Cash and cash equivalents are recorded at cost, which approximates fair value. Marketable Securities Marketable securities consist primarily of debt securities such as corporate bonds, commercial paper, U.S. treasury securities, and U.S. government agency securities. These securities are classified as available-for-sale securities at the time of purchase as they represent funds readily available for current operations, and the Company also has the ability and intent to liquidate them at any time to meet its operating cash needs, if necessary. All available-for-sale debt securities are recorded at their estimated fair value, with changes in fair value recognized as unrealized gains or losses in accumulated other comprehensive income. For available-for-sale debt securities in an unrealized loss position, the Company evaluates whether a current expected credit loss exists based on available information relevant to the credit rating of the security, current economic conditions and reasonable and supportable forecasts. Expected credit losses are recorded in other income (expense), net, on the consolidated statements of income, and any remaining unrealized losses are recognized in accumulated other comprehensive income or loss in the stockholders' equity section of the consolidated balance sheets. Realized gains and losses are determined based on the specific identification method and are reported in interest and other income, net in the consolidated statements of operations. There were no credit losses or impairment on available-for-sale debt securities recognized for the years ended December 31, 2022, 2021, and 2020. The Company is not aware of any specific event or circumstances that would require the Company to change its assessment of credit losses for any marketable available-for-sale debt securities as of December 31, 2022. Marketable securities also include mutual funds comprised of certain term bonds. These mutual funds meet certain criteria for equity investments in accordance with ASU 2016-01, Recognition and Measurement of Financial Assets and Liabilities. Under this guidance, the Company measures these mutual funds at their estimated fair value, with changes in fair value recognized in interest and other income, net in the consolidated statements of operations. Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are recorded at the invoiced amount, net of allowance for credit losses. The allowance is based on the Company’s assessment of the collectability of accounts and is recorded as an offset to revenue and deferred revenue. The Company regularly reviews the adequacy of the allowance by considering the age of each outstanding invoice and the collection history. Concentrations of Credit Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash and cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the years ended December 31, 2022, 2021, and 2020 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of December 31, 2022 and 2021. The Company primarily relies upon Amazon Web Services (AWS) to provide its cloud computing infrastructure, serve customers and operate certain aspects of its services. Any disruption of AWS's services would impact the Company's operations and its business could be adversely impacted. Deferred Contract Acquisition Costs Deferred contract acquisition costs are incremental costs that are associated with acquiring customer contracts and consist primarily of sales commissions and the associated payroll taxes and certain referral fees paid to third-party resellers. The costs incurred upon the execution of initial and expansion contracts are primarily deferred and amortized over an expected benefit period of three years. The expected benefit period is determined by taking into consideration the Company’s contracts with customers, technology life cycle and other factors. The Company considers the expected benefit period to exceed the initial contract term for certain costs because of anticipated renewals and because sales commission rates for renewal contracts are not commensurate with sales commissions for initial contracts. The Company includes amortization of deferred commissions in sales and marketing expense in its consolidated statements of operations. There was no impairment loss in relation to the incremental selling costs capitalized for the years ended December 31, 2022, 2021, and 2020. The Company has elected to apply the practical expedient under Accounting Standards Codification (ASC) No. 340-40—Other Assets and Deferred Costs to account for costs incurred in obtaining a contract with the expected benefit period of one year or less as commission expenses, which are included in sales and marketing expense in its consolidated statements of operations. Property and Equipment, net Property and equipment, net, including capitalized internally-developed software, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets as follows: Estimated Useful Life Computers 3 years Capitalized internal-use software 3 years Office equipment, furniture and fixtures 5 years Motor vehicles 5 years Leasehold improvements Lesser of lease term or 5 years Capitalized Internal-Use Software The Company capitalizes costs incurred in its software development projects as part of property and equipment during the application development stage. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Once the development project is available for general release, capitalization ceases, and the Company estimates the useful life of the asset and begins amortization. Internal-use software is amortized on a straight-line basis over its estimated useful life, which is generally three years. The Company also capitalizes certain costs related to its enterprise cloud computing services and certain projects for internal use incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Capitalized cloud computing costs are amortized on a straight-line basis over its estimated useful life. Long-Lived Assets (Including Goodwill and Intangible Assets) Long-lived assets with finite lives include property and equipment, capitalized internal-use software, right-of-use (ROU) assets and acquired intangible assets. The Company evaluates long-lived assets, including acquired intangible assets and capitalized internal-use software, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds these estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group. Goodwill is not amortized but rather is tested for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company elected to bypass the qualitative assessment, and performed a quantitative goodwill impairment test. Goodwill impairment is recognized when the quantitative assessment results in the carrying value of the reporting unit exceeding its fair value, in which case an impairment charge in the amount of such excess is recorded to goodwill, limited to the amount of goodwill. The Company did not recognize any impairment of goodwill during the years ended December 31, 2022, 2021, and 2020. Deferred Revenue Deferred revenue consists of customer billings in advance of revenue being recognized from the Company’s subscription and professional services arrangements. Customers are invoiced for subscription services arrangements in advance for monthly, quarterly, semi-annual and annual subscription plans. The Company’s payment terms generally provide that customers pay the invoiced portion of the total arrangement fee either in advance or within 30 days from the invoice date. Net Loss per Share Attributable to Common Stockholders Basic and diluted net loss per share attributable to common stockholders are presented in conformity with the two-class method required for participating securities. Under the two-class method, net income is attributed to common stockholders and participating securities based on their participation rights. Prior to the IPO, the Company considered all series of its redeemable convertible preferred stock to be participating securities. Net loss attributable to common stockholders was not allocated to the redeemable convertible preferred stock as the holders of the redeemable convertible preferred stock were not contractually obligated to share in the losses of the Company. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the number of weighted-average shares of common stock outstanding during the reporting period. Prior to the IPO, the net loss attributable to common stockholders was adjusted for accretion of the carrying value of redeemable convertible preferred stock and deemed dividend distribution. Since the Company has reported net losses for all periods presented, all potentially dilutive securities are considered antidilutive, and accordingly, diluted net loss per share is the same as basic net loss per share. Defined Benefit Plan Employees in India are entitled to benefits under the Gratuity Act, a defined benefit retirement plan covering eligible employees. The plan requires employers to provide for a lump-sum payment to eligible employees at retirement, death, and incapacitation or on termination of employment, of an amount based on the respective employee’s salary and tenure of employment. Employees in India are also entitled to a defined benefit plan with benefits based on an employee’s accumulated leave balance and salary. Both plans are unfunded arrangements. Current service costs are accrued in the period to which they relate. The benefit obligations are calculated by a qualified actuary using the projected unit credit method and the unfunded position is recognized as a liability in the consolidated balance sheets. In measuring the defined benefit obligations, the Company uses a discount rate at the reporting date based on yields of local government treasury bills denominated in the same currency in which the benefits are expected to be paid, with maturities approximating the terms of the Company’s obligations. Since the plan is unfunded, no annual contributions are required to be made as per applicable regulations. Disclosures required under ASC 715—Compensation—Retirement Benefits, have been omitted because the Company has deemed them immaterial to its consolidated financial statements. The benefit plans had a plan benefit obligation of $9.6 million and $7.4 million as of December 31, 2022 and 2021, respectively. The long-term portion for the amount of $8.6 million and $6.7 million is included in other liabilities in the consolidated balance sheets as of December 31, 2022 and 2021, respectively. The current portion for the amount of $1.0 million and $0.7 million is included in accrued expenses the consolidated balance sheets as of December 31, 2022 and 2021, respectively Leases The Company leases office space under operating leases with expiration dates through 2031. The Company determines whether an arrangement constitutes a lease and records lease liabilities and ROU assets on its consolidated balance sheets at the lease commencement date. Lease liabilities are measured based on the present value of the total lease payments not yet paid, discounted based on either the rate implicit in the lease or the Company's incremental borrowing rate (the estimated rate the Company would be required to pay for a collateralized borrowing equal to the total lease payments over the term of the lease), whichever is more readily determinable. The incremental borrowing rate is based on an estimate of the Company's expected unsecured borrowing rate for its notes, adjusted for tenor and collateralized security features. Lease liabilities due within 12 months are included within accrued liabilities on the Company's consolidated balance sheets. ROU assets are measured based on the corresponding lease liability adjusted for (i) payments made to the lessor at or before the lease commencement date, (ii) initial direct costs incurred, and (iii) tenant incentives received, incurred or payable under the lease. Recognition of rent expense begins when the lessor makes the underlying asset available to the Company. The Company does not assume renewals or early terminations of its leases unless it is reasonably certain to exercise these options at commencement and does not allocate consideration between lease and non-lease components. For short-term leases, the Company records rent expense in its consolidated statements of operations on a straight-line basis over the lease term and records variable lease payments as incurred. Recent Accounting Pronouncements Accounting Standards Adopted In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize most leases on their balance sheets as ROU assets with corresponding lease liabilities and eliminates certain real estate-specific provisions. The Company adopted this standard effective January 1, 2022 on a modified retrospective basis, and as such, results in comparative periods were not restated. As a result of the adoption, the Company recognized operating ROU assets of $24.3 million and operating lease liabilities of $28.8 million in its consolidated balance sheets on the adoption date. The Company has elected certain available practical expedients, which allow it to forego the reassessments of (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. The Company has also elected to combine lease and non-lease components for commercial lease arrangements. Additionally, the Company elected not to recognize operating ROU assets and the associated operating lease liabilities for leases with a term of 12 months or less from the lease commencement date. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets by requiring an allowance to be recorded as an offset to the amortized cost of such assets. The standard primarily impacts the amortized cost of the Company's available-for-sale debt securities. The Company adopted this standard on January 1, 2022 using the modified retrospective approach, which did not result in a material impact on its consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). The standard eliminates certain exceptions related to the approach for intraperiod tax allocation and the methodology for calculating income taxes in an interim period. The standard also simplifies aspects of accounting for franchise taxes and enacted changes in tax or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis for goodwill. The Company adopted this standard effective January 1, 2022, which did not result in a material impact on its consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. ASU 2021-08 will become effective for the Company on January 1, 2023, to be applied prospectively to business combinations occurring on or after the effective date of the ASU, with early adoption permitted. The Company adopted this standard effective January 1, 2022, which did not result in any impact on its consolidated financial statements. Effective December 31, 2022, the Company is no longer an emerging growth company. As a result, the Company started adopting new or revised accounting pronouncements at dates applicable to public companies. |
Revenue from Contracts with Cus
Revenue from Contracts with Customers | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue from Contracts with Customers | Revenue From Contracts with Customers Disaggregation of Revenue The following table summarizes revenue by the Company’s service offerings (in thousands): Year Ended December 31, 2022 2021 2020 Subscription services $ 485,322 $ 360,506 $ 242,879 Professional services 12,677 10,516 6,780 Total revenue $ 497,999 $ 371,022 $ 249,659 See Note 13 for revenue by geographic location. Deferred Revenue and Remaining Performance Obligations Deferred revenue consists of customer billings in advance of revenue being recognized from the Company’s subscription and professional services arrangements. The following table summarizes the changes in the balance of deferred revenue during the years (in thousands): Year Ended December 31, 2022 2021 2020 Balance at beginning of the year $ 160,173 $ 104,184 $ 67,540 Add: Billings during the year 543,452 427,011 286,303 Less: Revenue recognized during the year (497,999) (371,022) (249,659) Balance at end of the year $ 205,626 $ 160,173 $ 104,184 Revenue recognized during the years ended December 31, 2022, 2021, and 2020 from amounts included in deferred revenue at the beginning of these periods was $158.7 million, $103.8 million, and $67.5 million, respectively. The aggregate balance of remaining performance obligations as of December 31, 2022 was $301.5 million. The Company expects to recognize $234.7 million of the balance as revenue in the next 12 months and the remainder thereafter. The aggregate balance of remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Deferred Contract Acquisition Costs The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Year Ended December 31, 2022 2021 2020 Balance at beginning of the year $ 29,647 $ 18,273 $ 11,610 Add: Contract costs capitalized during the year 28,560 24,218 14,344 Less: Amortization of contract costs during the year (18,532) (12,844) (7,681) Balance at end of the year $ 39,675 $ 29,647 $ 18,273 |
Cash Equivalents and Marketable
Cash Equivalents and Marketable Securities | 12 Months Ended |
Dec. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Cash Equivalents and Marketable Securities | Cash Equivalents and Marketable Securities Cash equivalents and available-for-sale debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands): December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 219,512 $ — $ — $ 219,512 U.S. treasury securities 13,912 3 — 13,915 U.S. government agency securities 10,417 2 — 10,419 Corporate debt securities 1,995 1 — 1,996 Total cash equivalents 245,836 6 — 245,842 Debt securities: U.S. treasury securities 441,909 36 (3,160) 438,785 U.S. government agency securities 301,009 35 (3,531) 297,513 Corporate debt securities 106,436 — (817) 105,619 Total debt securities 849,354 71 (7,508) 841,917 Total cash equivalents and debt securities $ 1,095,190 $ 77 $ (7,508) $ 1,087,759 December 31, 2021 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 684,485 $ — $ — $ 684,485 U.S. treasury securities 22,000 — — 22,000 U.S. government agency securities 4,286 — (1) 4,285 Corporate debt securities 15,998 — — 15,998 Total cash equivalents 726,769 — (1) 726,768 Debt securities: U.S. treasury securities 442,715 2 (432) 442,285 U.S. government agency securities 75,725 — (159) 75,566 Corporate debt securities 54,335 17 (175) 54,177 Total debt securities 572,775 19 (766) 572,028 Total cash equivalents and debt securities $ 1,299,544 $ 19 $ (767) $ 1,298,796 The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of December 31, 2022 (in thousands): December 31, 2022 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 190,820 $ (1,794) $ 105,115 $ (1,366) $ 295,935 $ (3,160) U.S. government agency securities 220,766 (2,245) 42,754 (1,286) 263,520 (3,531) Corporate debt securities 30,485 (455) 22,864 (362) 53,349 (817) Total $ 442,071 $ (4,494) $ 170,733 $ (3,014) $ 612,804 $ (7,508) As of December 31, 2021, there were no securities that have been in a continuous unrealized loss position for 12 months or longer. The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): December 31, 2022 Amortized Cost Fair Value Due within one year $ 608,359 $ 604,039 Due after one year but within five years 240,995 237,878 Total $ 849,354 $ 841,917 Accrued interest receivable of $2.8 million was classified as prepaid expenses and other current assets In addition to available-for-sale debt securities, marketable securities also include term bond mutual funds, which are measured at fair value. As of December 31, 2022 and 2021, the fair value of the term bond mutual funds was $1.5 million and $3.7 million, respectively. The change in fair value of the term bond mutual funds is recorded in interest and other income, net in the consolidated statements of operations. The realized and unrealized gains recognized in the consolidated statements of operations for the term bond mutual funds were not material during the years ended December 31, 2022, 2021, and 2020. Non-Marketable Equity Securities Non-marketable equity securities represent the Company's interest in privately-held entities. The Company does not have significant influence over these investments, which do not have readily determinable fair values. Under ASU 2016-01, the Company has elected the measurement alternative to carry them at cost, less any impairment charges, and reports them under other assets in the consolidated balance sheets. In September 2021, the Company sold its interest in a privately held entity for proceeds totaling $24 million, resulting in a gain of $23.8 million, which was recorded in interest and other income, net, in the consolidated statements of operations. As of December 31, 2022 and December 31, 2021, the Company's non-marketable equity securities were not material. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable. Money market funds and U.S. treasury securities are classified within Level 1 because they are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Other debt securities and investments are classified within Level 2 if the investments are valued using model driven valuations which use observable inputs such as quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Available-for-sale debt securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. The Company did not have any assets or liabilities subject to fair value remeasurement on a nonrecurring basis as of December 31, 2022 and 2021. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of December 31, 2022 and 2021 (in thousands): December 31, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 219,512 $ — $ 219,512 U.S. treasury securities 13,915 — 13,915 U.S. government agency securities — 10,419 10,419 Corporate debt securities — 1,996 1,996 Marketable securities: U.S. treasury securities 438,785 — 438,785 U.S. government agency securities — 297,513 297,513 Corporate debt securities — 105,619 105,619 Term bond mutual funds — 1,488 1,488 Total financial assets $ 672,212 $ 417,035 $ 1,089,247 December 31, 2021 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 684,485 $ — $ 684,485 U.S. treasury securities 22,000 — 22,000 U.S. government agency securities — 4,285 4,285 Corporate debt securities — 15,998 15,998 Marketable securities: U.S. treasury securities 442,285 — 442,285 U.S. government agency securities — 75,566 75,566 Corporate debt securities — 54,177 54,177 Term bond mutual funds — 3,651 3,651 Total financial assets $ 1,148,770 $ 153,677 $ 1,302,447 |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Balance Sheet Components | Balance Sheet Components Property and Equipment, net The following table summarizes property and equipment, net as of December 31, 2022 and 2021 (in thousands): December 31, 2022 2021 Computers $ 16,552 $ 13,041 Capitalized internal-use software 20,230 14,178 Office equipment 3,744 3,375 Furniture and fixtures 8,881 8,395 Motor vehicles 1,158 1,421 Leasehold improvements 5,654 4,274 Construction in progress 224 — Total property and equipment 56,443 44,684 Less: accumulated depreciation and amortization (32,304) (23,206) Property and equipment, net $ 24,139 $ 21,478 Capitalization of costs associated with internal-use software were $6.8 million, $4.1 million and $4.6 million for the years ended December 31, 2022, 2021 and 2020, respectively. Amortization expense of capitalized internal-use software was $3.2 million, $2.5 million and $1.5 million for the years ended December 31, 2022, 2021, and 2020, respectively. As of December 31, 2022 and 2021, the net carrying value of capitalized internal-use software was $11.2 million and $8.3 million, respectively. Depreciation expense for the years ended December 31, 2022, 2021, and 2020 totaled $6.7 million, $6.5 million, and $5.4 million, respectively. Accrued and Other Liabilities The following table summarizes accrued liabilities as of December 31, 2022 and 2021 (in thousands): December 31, 2022 2021 Accrued compensation $ 20,192 $ 17,261 Accrued third-party cloud infrastructure expenses 2,752 2,785 Accrued reseller commissions 7,731 5,870 Accrued advertising and marketing expenses 4,465 6,022 Advanced payments from customers 3,480 3,260 Accrued taxes 7,730 10,777 Operating lease liabilities, current 6,775 — Contributions withheld for employee stock purchase plan 1,546 4,211 Other accrued expenses 4,337 5,643 Total accrued liabilities $ 59,008 $ 55,829 Noncurrent liabilities include $23.3 million and $14.9 million of long term accrued compensation as of December 31, 2022 and 2021, respectively. |
Business Combination, Asset Pur
Business Combination, Asset Purchase and Intangible Assets, Net | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Business Combination, Asset Purchase and Intangible Assets, Net | Business Combination, Asset Purchase and Intangible Assets, Net Business Combinations and Asset Purchases From time to time, the Company makes acquisitions of, or investments in companies or enters into asset purchase agreements that could enhance the functionality and features of the Company's software platform. In 2020, Freshworks completed a business acquisition and asset purchase which were not material. Substantially all of the consideration of the business acquisition was allocated to acquisition-related intangible assets and goodwill. Intangible Assets, Net Acquired intangible assets consist of developed technology and customer relationships and are amortized on a straight-line basis over their estimated useful lives. The following tables summarize acquired intangible assets as of December 31, 2022 and 2021 (amounts in thousands): December 31, 2022 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (in years) Developed technology $ 10,496 $ (10,338) $ 158 0.2 Customer relationships 1,600 (1,455) 145 0.4 Total $ 12,096 $ (11,793) $ 303 December 31, 2021 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (in years) Developed technology $ 10,496 $ (9,147) $ 1,349 0.9 Customer relationships 1,600 (1,055) 545 1.4 Total $ 12,096 $ (10,202) $ 1,894 Total amortization of acquired intangible assets for the years ended December 31, 2022, 2021, and 2020 is as follows (in thousands): Year Ended December 31, 2022 2021 2020 Developed technology Cost of revenue $ 1,191 $ 3,929 $ 3,867 Customer relationships: Sales and marketing $ 400 400 401 Total amortization expense $ 1,591 $ 4,329 $ 4,268 As of December 31, 2022, the net book value of acquired intangible assets is expected to be fully amortized during the year ending December 31, 2023. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases The Company has operating leases primarily for office space. The leases have remaining lease terms of one The following table presents various components of the lease costs (in thousands): Operating Leases December 31, 2022 Operating lease cost $ 8,312 Short-term lease cost 1,162 Variable lease cost 2,797 Rent expense for operating leases recognized prior to our adoption of Topic 842 for the years ended December 31, 2021 and 2020 was $9.7 million and $10.2 million, respectively. The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate December 31, 2022 Weighted-average remaining lease term (in years) 4.81 Weighted-average discount rate 7.4 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Year Ended Supplemental Cash Flow Information: December 31, 2022 Cash payments included in the measurement of operating lease liabilities $ 8,885 Operating ROU assets obtained in exchange for lease obligations 14,903 Maturities of the operating lease liabilities are as follows (in thousands): Year Ending December 31: Operating Leases 2023 $ 9,186 2024 9,715 2025 8,759 2026 5,499 2027 4,206 Thereafter 5,760 Total lease payments 43,125 Less: imputed interest (8,176) Present value of operating lease liabilities $ 34,949 As of December 31, 2022, there were no future payments related to signed leases that have not yet commended. Future minimum lease payments under non-cancelable operating leases as of December 31, 2021, were as follows (in thousands): Year ending December 31, Operating Leases 2022 $ 6,954 2023 6,790 2024 6,642 2025 5,976 2026 3,579 Thereafter 4,304 Total minimum future payments $ 34,245 |
Commitment and Contingencies
Commitment and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Other Contractual Commitments The Company's other contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription purchase arrangements used to support operations at the enterprise level. Future minimum payments under the Company’s non-cancelable purchase commitments as of December 31, 2022 are presented in the table below (in thousands): Year ending December 31, Contractual Commitments 2023 $ 46,191 2024 46,965 2025 11,982 Total $ 105,138 Litigation and Loss Contingencies On November 1, 2022, a purported Company stockholder filed a securities class action complaint in the U.S. District Court for the Northern District of California against us, certain of our current officers and directors, and underwriters of the IPO. The complaint alleges that defendants violated Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 by making material misstatements or omissions in offering documents filed in connection with the IPO. The complaint seeks unspecified damages, interest, fees, costs, and rescission on behalf of purchasers and/or acquirers of common stock issued in the IPO. The Company and the other defendants intend to vigorously defend against the claims in this action. From time to time, the Company may be subject to other legal proceedings, claims, investigations, and government inquiries (collectively, Legal Proceedings) in the ordinary course of business. It may receive claims from third parties asserting, among other things, infringement of their intellectual property rights, defamation, labor and employment rights, privacy, and contractual rights. There are no currently pending legal proceedings that the Company believes will have a material adverse impact on the business or consolidated financial statements. Indemnifications In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to customers, business partners, and other parties with respect to certain matters, including losses arising out of intellectual property infringement claims made by third parties, if the Company has violated applicable laws, if the Company is negligent or commits acts of willful misconduct, and other liabilities with respect to its products and services and its business. In these circumstances, payment is typically conditional on the other party making a claim pursuant to the procedures specified in the particular contract. The Company also indemnifies certain of its officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, the Company has not incurred any material costs as a result of such indemnifications and has not accrued any liabilities related to such obligations in its consolidated financial statements. |
Stockholders' Equity and Stock
Stockholders' Equity and Stock Based Compensation | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Stockholders' Equity and Stock Based Compensation | Stockholders' Equity and Stock Based Compensation Common Stock The Company has two classes of common stock: Class A common stock and Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to ten votes. Class A and Class B common stock are referred to as common stock throughout these notes to the consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Shares of Class B common stock automatically convert to Class A common stock upon the following: (1) sale or transfer of such share of Class B common stock, except for certain permitted transfers as described in our amended and restated certificate of incorporation; (2) the death of such Class B common stockholder (or nine months after the date of death if the stockholder is our founder); and (3) on the final conversion date, defined as the earlier of (a) the last trading day of the fiscal year following the seventh anniversary of the Company's IPO; or (b) the date specified by a vote of the holders of a majority of the outstanding shares of Class B common stock, voting as a single class. Comprehensive Loss Comprehensive loss is comprised of two components—net loss and other comprehensive (loss) income. Other comprehensive (loss) income includes unrealized gains or losses on available-for-sale debt securities recognized during the period. The following tables shows the change in unrealized gains or losses within accumulated other comprehensive (loss) income: Year Ended December 31, 2022 2021 2020 Beginning balance $ (747) $ 411 $ 139 Unrealized (losses) gains on available-for-sale debt securities (6,684) (1,152) 405 Reclassification of unrealized gains to interest and other income, net, in the consolidated statements of operations — (6) (133) Net impact to other comprehensive (loss) income in current period (6,684) (1,158) 272 Ending balance $ (7,431) $ (747) $ 411 Equity Compensation Plans In August 2021, the board of directors (the Board) adopted the 2021 Equity Incentive Plan (the 2021 Plan) and the 2021 Employee Stock Purchase Plan (ESPP), effective upon the Company's IPO. Pursuant to the 2021 Plan, the Board may grant incentive stock options to purchase shares of the Company’s common stock, non-statutory stock options to purchase shares of the Company’s common stock, stock appreciation rights, restricted stock, RSUs, performance awards (PRSUs) and other awards. The ESPP enables eligible employees to purchase the Company's Class A common stock. Both the 2021 Plan and ESPP include an automatic increase to their shares reserve on January 1 of each year as set forth in the respective plan documents. In August 2022, the Board adopted the 2022 Inducement Plan (the Inducement Plan) in accordance with Listing Rule 5635(c)(4) of the Nasdaq Stock Market. Under the Inducement Plan, nonstatutory stock options, stock appreciation rights, restricted stock, RSUs, PRSUs and other awards may be granted as an inducement material for eligible persons to enter into employment with the Company. Upon adoption, the Company has initially reserved 10,000,000 shares of Class A common stock for issuance under the Inducement Plan. In September 2022, the Company hired a President and granted him 1,732,501 RSUs under the Inducement Plan and stock options to purchase up to 1,815,980 shares of Class A common stock, of which stock options to purchase up to 1,776,780 shares of Class A common stock were granted under the Inducement Plan and the remaining under the 2021 Plan. Each award will vest over four years with 25% of the shares vesting on the first anniversary of the grant date and the remaining 75% of the shares vesting in equal quarterly installments thereafter, subject to continued employment. Shares of common stock reserved for future issuance were as follows (in thousands): December 31, 2022 2011 Stock Plan: Options and RSUs outstanding 21,380 2021 Equity Incentive Plan: RSUs outstanding 10,122 Shares reserved for future award issuances 52,178 2022 Inducement Plan: Options and RSUs outstanding 3,509 Shares reserved for future award issuances 6,491 2021 Employee Stock Purchase Plan 8,371 Total shares of common stock reserved for issuance 102,051 Employee Stock Purchase Plan Under the ESPP, the price at which common stock is purchased is equal to 85% of the fair market value of a share of the Company’s common stock on the first day of the offering period or the applicable purchase date, whichever is lower. The fair market value of common stock will generally be the closing sales price on the determination date. The ESPP provides an offering period of 24 months, with four purchase periods that are generally six months long and end on May 15 and November 15 of each year, except for the first purchase period, which began upon the completion of the IPO in September 2021 and ended on May 13, 2022. The Company issued 822,423 shares under the ESPP during the year ended December 31, 2022, net of shares withheld and retired to satisfy withholding tax requirements for certain employees in jurisdictions outside the United States, with a weighted average purchase price of $13.33 and aggregate net proceeds of $10.9 million. During the year ended December 31, 2021, no shares were purchased under the ESPP. The ESPP also includes a reset provision for the purchase price if the fair market value of a share of the Company's common stock on the first day of any purchase period is less than or equal to the fair market value of a share of the Company's common stock on the first day of an ongoing offering. If the reset provision is triggered, a new 24-month offering period begins. The reset provision under the ESPP was triggered on May 16, 2022, and again on November 16, 2022. Each triggering of the reset provision was considered a modification in accordance with ASC 718, Stock Based Compensation , with the modification charge recognized on a straight-line basis over the new offering period. The modifications did not have a material effect on the Company's stock-based compensation expense during the year ended December 31, 2022. As of December 31, 2022 and 2021, the Company has withheld $1.5 million and $4.2 million of contributions from its employees. During the years ended December 31, 2022 and 2021, the Company recognized $12.2 million and $3.5 million of stock-based compensation expense related to the ESPP, respectively. Determination of Fair Value of the ESPP The Company estimates the fair value of the ESPP using the Black-Scholes option-pricing model, which requires certain complex valuation assumption inputs such as expected term, expected stock price volatility, risk-free interest rate and dividend yield. The fair value of each of the four purchase periods is estimated separately. The following table summarizes the range of valuation assumptions used in estimating the fair value of the ESPP during the period: Year Ended December 31, Valuation Assumption Inputs 2022 2021 Expected term (in years) 0.5 - 2.0 0.6 - 2.1 Stock price volatility 55.8% - 84.5% 47.7% - 58.5% Risk-free interest rate 1.54% - 4.62% 0.06% - 0.29% Dividend yield 0.00% 0.00% Stock Options Stock options are granted with an exercise price equal to the stock’s fair market value at the date of grant, have a 10-year contractual term, and vest over a four-year period. Stock option activity during the year ended December 31, 2022 is as follows (in thousands, except per share data): Share Information: Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (1) Balance as of December 31, 2021 1,348 $ 0.27 3.6 $ 35,020 Stock options granted 1,816 $ 13.61 Stock options exercised (406) $ 0.27 Stock options cancelled / forfeited / expired — $ — Balance as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Options vested and expected to vest as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Options exercisable as of December 31, 2022 942 $ 0.27 2.7 $ 13,598 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested. Total intrinsic value of options exercised during the years ended December 31, 2022, 2021, and 2020 was $5.9 million, $14.0 million, and $9.8 million, respectively. The weighted-average grant date fair value of stock options granted was $8.26 per share during the year ended December 31, 2022. There were no options granted during the years ended December 31, 2021 and 2020. Determination of Fair Value of Stock Options The Company estimates the fair value of stock options using the Black-Scholes option-pricing model, which requires certain complex valuation assumption inputs such as expected term, expected stock price volatility, risk-free interest rate, and dividend yield. The following table summarizes the valuation assumptions used in estimating the fair value of stock options granted during the year: Year Ended December 31, Valuation Assumption Inputs 2022 Expected term (in years) 6.1 Stock price volatility 65.0% Risk-free interest rate 3.37% Dividend yield —% Restricted Stock Units RSUs are granted at fair market value at the date of the grant and vest over a four-year period. RSU activity, which includes PRSUs, during the year ended December 31, 2022 is as follows (in thousands, except per share data): Share Information: Number of Shares Weighted-Average Grant Date Fair Value Unvested, as of December 31, 2021 47,830 $ 14.47 Granted 13,054 $ 16.88 Vested (1) (24,397) $ 9.63 Forfeited (4,234) $ 16.24 Unvested, as of December 31, 2022 32,253 $ 18.86 (1) During the year ended December 31, 2022 total shares that vested were 24.4 million, of which 9.8 million shares were withheld for tax withholding requirements. The total fair value of vested RSUs during the years ended December 31, 2022, 2021, and 2020 were $235.0 million, $51.3 million, and zero, respectively. Performance-Based Awards In May 2019, the Board approved a grant of 166,390 shares PRSUs to the Company’s CEO. The vesting of these PRSUs is contingent upon the satisfaction of certain milestones. The revenue-related milestone and the liquidity event condition were met prior to December 31, 2021 upon the completion of the IPO as described in Note 1 - Description of Business . Upon completion of the IPO, the time-based vesting was the only condition yet to be satisfied over the remaining requisite service period. The number of shares to vest subject to this condition is insignificant. In September 2021, the Board approved a grant of 6,000,000 PRSUs to the Company's CEO with a time-based service condition beginning January 1, 2022, and a market condition involving five separate stock price targets ranging from $70.00 to $200.00 per share for each of the five vesting tranches (CEO Performance Award). These stock price targets are measured based on the average closing price over a consecutive 60-trading day period, beginning on the first trading day after the expiration of the final lock-up period in February 2022. The vesting of the CEO Performance Award is contingent upon the completion of the requisite service through January 1, 2029 and the achievement of the specified stock price target in each tranche on or before January 1, 2029. The stock price targets are not required to be achieved within the service period of each tranche, and accordingly, multiple tranches can vest at the same date if the specified stock price targets are achieved after December 31, 2025. The CEO Performance Award had a total grant date fair value of $131.0 million. The fair value of the CEO Performance Award was determined at grant date by using the Monte Carlo simulation model, which requires certain complex valuation assumption inputs such as measurement period, expected stock price volatility, risk-free interest rate and dividend yield. The valuation assumptions using the Monte Carlo simulation model at the date of grant were: Valuation Assumption Inputs Measurement period (in years) 7.0 Stock price volatility 60.0% Risk-free interest rate 1.12% Dividend yield —% For the years ended December 31, 2022 and 2021, the Company recognized $27.6 million and $9.0 million of stock-based compensation expense associated with performance-based awards, respectively, which were primarily related to the CEO Performance Award. There were no stock-based compensation expense associated with performance-based awards during the year ended December 31, 2020. Stock-Based Compensation Total stock-based compensation expense recorded for the years ended December 31, 2022, 2021, and 2020 was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Equity awards: Cost of revenue $ 7,039 $ 5,604 $ — Research and development (1) 36,413 45,162 8 Sales and marketing (2) 64,328 53,169 7 General and administrative (3) 99,916 69,508 29 Total employee awards 207,696 173,443 44 Secondary transaction — — 43,236 Stock-based compensation, net of amounts capitalized 207,696 173,443 43,280 Capitalized stock-based compensation 1,665 585 — Total stock-based compensation expense $ 209,361 $ 174,028 $ 43,280 (1) Stock-based compensation expense recorded to research and development in the consolidated statements of operations excludes amounts that were capitalized for internal-use software for the years ended December 31, 2022 and 2021. (2) Sales and marketing expense for the year ended December 31, 2022 includes $3.2 million of stock-based compensation expense associated with RSU and options granted to the President in September 2022. (3) General and administrative expense includes $55.9 million and $19.1 million of stock-based compensation expense associated with RSUs and PRSUs primarily granted to the CEO in September 2021 for the years ended December 31, 2022 and 2021, respectively. For the year ended December 31, 2021, stock-based compensation expense of $173.4 million included a cumulative charge associated with certain RSUs for which the service-based vesting condition was satisfied upon the completion of the IPO (liquidity event), as further described in Note 1— Description of Business. During the year ended December 31, 2020, stock-based compensation included expenses recognized from employee stock-based awards, and the excess value of $43.2 million paid to repurchase shares in a secondary transaction. The excess value was comprised of $10.8 million recorded in general and administrative expense for the repurchase of redeemable convertible preferred stock (as described below), and $32.4 million for the repurchases of shares of common stock from the Company’s founders and a number of employees, of which $16.5 million and $15.9 million were recorded in general and administrative expense and research and development, respectively. In January 2020, an investor, also a member of the Board at that time, entered into a secondary transaction to sell 26,210 shares of redeemable convertible Series A preferred stock, 1,314,830 shares of redeemable convertible Series B preferred stock, and 448,110 shares of redeemable convertible Series C preferred stock to a new investor for a total price in excess of the fair value of the shares. The sale was facilitated by the Company and deemed compensatory to the seller. The amount paid by the investor to acquire the shares was $25.5 million, while the fair value of the shares on the transaction date was $14.7 million. The excess value of $10.8 million was recognized as stock-based compensation expense. As of December 31, 2022, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): December 31, 2022 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense (in years) RSUs and PSUs $ 531,758 3.0 Stock options 13,758 3.7 ESPP 12,606 1.1 Total unrecognized stock-based compensation expense $ 558,122 |
Net Loss Per Share
Net Loss Per Share | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | Net Loss Per Share Basic net loss per share attributable to common stockholders is computed by dividing the net loss by the number of weighted-average outstanding common shares. Diluted net loss per share attributable to common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result. The Company considers its redeemable convertible preferred stock, stock options and RSUs as potential common stock equivalents, but excluded them from the computation of diluted net loss per share attributable to common stockholders in the periods presented, as their effect was antidilutive. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are the same for both Class A and Class B common stock on both an individual and combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Numerator: Net loss $ (232,132) $ (191,995) $ (57,294) Accretion of redeemable convertible preferred stock — (2,646,662) (1,560,524) Net loss attributable to Class A and Class B common stockholders - basic and diluted $ (232,132) $ (2,838,657) $ (1,617,818) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 284,587 130,652 76,945 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.82) $ (21.73) $ (21.03) The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Year Ended December 31, 2022 2021 2020 Redeemable convertible preferred stock — — 153,938 RSUs and PRSUs 32,253 47,830 33,928 Stock options 2,758 1,348 2,096 ESPP 124 160 — Total 35,135 49,338 189,962 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company’s net loss before provision for income taxes for the years ended December 31, 2022, 2021, and 2020 was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Domestic $ (252,261) $ (211,844) $ (69,102) Foreign 31,471 30,365 15,823 Total $ (220,790) $ (181,479) $ (53,279) The components of the provision for income taxes for the years ended December 31, 2022, 2021, and 2020 were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Current: Domestic $ 2,137 $ 2,876 $ (12) Foreign 11,610 9,547 6,387 Deferred: Domestic — — — Foreign (2,405) (1,907) (2,360) Total provision for income taxes $ 11,342 $ 10,516 $ 4,015 The following is a reconciliation of the federal statutory income tax rate to the Company’s effective tax rate for the years ended December 31, 2022, 2021, and 2020: Year Ended December 31, 2022 2021 2020 Federal income tax 21.0 % 21.0 % 21.0 % Stock-based compensation (1.6) 2.1 (17.1) Change in valuation allowance (22.4) (25.4) (11.8) Earnings from foreign subsidiaries (1.2) (0.5) (1.3) Other items (0.9) (3.0) 1.6 Total provision for income taxes (5.1) % (5.8) % (7.6) % The components of the Company’s net deferred tax assets as of December 31, 2022 and 2021, were as follows (in thousands): December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 100,090 $ 78,077 Foreign tax credit carryforwards 4,955 4,955 Capitalized R&E under IRC 174 36,970 — Stock-based compensation 4,337 9,643 Accruals and Reserves 9,032 6,584 Depreciation and amortization 1,449 1,633 Allowance for uncollectible accounts 212 66 Operating lease liability 19,207 — Total deferred tax assets 176,252 100,958 Less: valuation allowance (146,134) (89,903) Deferred tax assets, net of valuation allowance 30,118 11,055 Deferred tax liabilities: Commissions (6,146) (4,771) Operating lease right-of-use assets (15,283) — Net deferred tax assets $ 8,689 $ 6,284 The Company regularly reviews its deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing taxable temporary differences and tax planning strategies. The Company’s judgment regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute the business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the Company’s income tax provision would increase or decrease in the period in which the assessment is changed. The Company’s valuation allowance increased by $56.2 million and $48.8 million during the years ended December 31, 2022 and 2021, respectively. The Tax Cuts and Jobs Act of 2017 (TCJA) made a significant change to Internal Revenue Code Section 174, which went into effect for taxable years beginning after December 31, 2021. The change requires Companies to capitalize specific research and experimental (“R&E”) expenditures and amortize over five years for U.S. incurred R&E or fifteen years for foreign incurred R&E beginning on January 1, 2022. Since the Company generated enough pre-tax loss in 2022, this legislation did not result in an increase in U.S. federal and state cash tax payments. The Company has not provided U.S. income taxes and foreign withholding taxes on undistributed earnings of foreign subsidiaries because the Company intends to permanently reinvest such earnings outside the United States. Net Operating Loss and Credit Carryforwards As of December 31, 2022, the Company has U.S. federal net operating loss carryforwards of approximately $429.6 million, of which $10.7 million are subject to limitation under Internal Revenue Code Section 382 (IRC Section 382). The net operating loss carryforwards for all the states in the United States is $151.4 million as of December 31, 2022. The federal net operating loss carryforwards that were generated prior to the 2018 tax year will begin to expire in 2030 if not utilized. For net operating loss carryforwards arising in tax years beginning after December 31, 2017, the Tax Act limits the Company’s ability to utilize carryforwards to 80% of taxable income, however, these operating losses may be carried forward indefinitely. The state net operating loss carryforwards will begin to expire in 2032 if not utilized. The Company has foreign tax credits of $5.0 million that will expire in 2027 if not utilized. Utilization of the net operating loss carryforwards may be subject to a substantial annual limitation due to the ownership change provisions of IRC Section 382 and similar state provisions. The annual limitation may result in the inability to fully offset future annual taxable income and could result in the expiration of net operating loss carryforwards before utilization. The Company continually monitors the impact to net operating losses of any ownership changes. Unrecognized Tax Benefits The Company has adopted authoritative guidance which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the Company’s income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company recognizes financial statement benefit of a tax position only after determining that the relevant tax authority would more-likely-than-not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has no likelihood of being realized upon ultimate settlement with the relevant tax authority. As of December 31, 2022 and 2021, the Company had gross unrecognized tax benefits of $3.6 million and $2.2 million, respectively, all of which would affect income tax expense, if recognized, after consideration of valuation allowance. The Company did not have any unrecognized tax benefits with a significant impact on its financial statements as of December 31, 2020. The following table presents a reconciliation of the beginning and ending amount of the unrecognized tax benefits (in thousands): Year Ended December 31, 2022 2021 Unrecognized gross tax benefits at the beginning of the period $ 2,227 $ — Increases related to prior year tax positions — 1,269 Decreases related to prior year tax positions (6) — Increases in current year unrecognized benefits 1,426 958 Unrecognized gross tax benefits at the end of the period $ 3,647 $ 2,227 The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. Accrued interest of $0.8 million and $0.5 million has been recorded as of December 31, 2022 and 2021, respectively. The Company's major tax jurisdictions are India and the United States and also files income tax returns in various U.S. states and foreign jurisdictions. Carryover attributes beginning December 31, 2008, remain open to adjustment by the U.S. federal and state authorities. The U.S. federal, state, and foreign jurisdictions have statutes of limitations that generally range from three to five years. Due to the Company’s net losses, substantially all of its federal and state income tax returns are subject to examination since inception. As of December 31, 2022, the Company is currently under examinations in India and Germany. The Company believes that it has provided adequate reserves for its income tax uncertainties in all open tax years. As the outcome of the Company's tax audits are resolved in a manner inconsistent with management's expectations, the Company could adjust its provision for income taxes in the future. |
Geographic Information
Geographic Information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Geographic Information | Geographic Information Revenue by geographic location is determined based on the customers' billing address. The following table summarizes revenue by geographic region (in thousands): Year Ended December 31, 2022 2021 2020 North America $ 216,112 $ 160,224 $ 111,644 Europe, Middle East and Africa 193,899 152,542 98,992 Asia Pacific 74,948 49,933 33,445 Other 13,040 8,323 5,578 Total revenue $ 497,999 $ 371,022 $ 249,659 Revenue from North America primarily includes revenue from the United States. For the years ended December 31, 2022, 2021 and 2020, revenue generated from the United States was $192.2 million, $142.9 million and $99.2 million, or 39%, 39% and 40% of total consolidated revenue, respectively. The United Kingdom, categorized within Europe, Middle East and Africa in the table above, contributed $63.8 million $52.9 million and $33.2 million or 13%, 14% and 13% of total consolidated revenue for the years ended December 31, 2022, 2021 and 2020, respectively. Long-lived assets consist primarily of property, plant and equipment and ROU assets. The following table summarizes long-lived assets by geographic information (in thousands): December 31, 2022 2021 North America $ 23,839 $ 13,780 Europe, Middle East and Africa 4,039 578 Asia Pacific 29,285 9,015 Total long-lived assets $ 57,163 $ 23,373 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. |
Foreign Currency Remeasurement and Transactions | Foreign Currency Remeasurement and TransactionsThe functional currency of the Company’s foreign subsidiaries is the U.S. dollar. Accordingly, each foreign subsidiary remeasures monetary assets and liabilities at period-end exchange rates, while non-monetary items are remeasured at historical rates. Revenues and expenses are remeasured at the exchange rates in effect on the day the transaction occurred, except for those expenses related to non-monetary assets and liabilities, which are remeasured at historical exchange rates. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of acquired intangible assets and goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan and other compensation liabilities; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases. |
Segment Information | Segment Information The Company operates in a single operating segment. The Chief Executive Officer (CEO) is the chief operating decision maker of the Company and makes operating decisions, assesses financial performance, and allocates resources based upon discrete financial information at a consolidated level. |
Revenue Recognition and Deferred Revenue | Revenue Recognition The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes. The Company sells subscriptions to third-party resellers. The price at which subscriptions are sold to the reseller is typically discounted, as compared to the price at which the Company would sell to an end customer, in order to enable the reseller to realize a margin on the eventual sale to the end customer. As pricing to the reseller is fixed, and the Company lacks visibility into the pricing provided by the reseller to the end customer, reseller revenue is recorded net of any reseller discounts. Subscription Revenue Subscription revenue is primarily comprised of fees paid by the Company’s customers for accessing its cloud-based software during the term of the arrangement. Cloud-based services allow customers to use the Company’s multi-tenant software without requiring them to take possession of the software. Given that access to the cloud-based software represents a series of distinct services that comprise a single performance obligation that is satisfied over time, subscription revenue is recognized ratably over the contract term beginning on the commencement date of each contract, which is the date that the cloud-based software is made available to customers. Professional Services Revenue Professional services revenue is comprised of fees charged for services ranging from product configuration, data migration, systems integration, and training. The Company recognizes professional services revenues as services are performed. Customers with Multiple Performance Obligations Some of the Company’s contracts with customers contain both subscriptions and professional services. For these contracts, the Company accounts for individual performance obligations separately. The transaction price is allocated to the separate performance obligations on the basis of relative standalone selling price (SSP). The Company determines SSP by taking into Deferred Revenue Deferred revenue consists of customer billings in advance of revenue being recognized from the Company’s subscription and professional services arrangements. Customers are invoiced for subscription services arrangements in advance for monthly, quarterly, semi-annual and annual subscription plans. The Company’s payment terms generally provide that customers pay the invoiced portion of the total arrangement fee either in advance or within 30 days from the invoice date. |
Cost of Revenue | Cost of Revenue Cost of revenue consists primarily of personnel-related expenses (primarily including salaries, related benefits, and stock-based compensation) for employees associated with the Company’s cloud-based infrastructure, payment gateway fees, voice, product support, and professional service organizations, as well as costs incurred by the Company for third-party hosting capabilities. Cost of revenue also includes third-party license fees, amortization of acquired intangibles, amortization of capitalized internal-use software, and allocation of general overhead expenses such as facilities and information technology. |
Research and Development | Research and DevelopmentResearch and development costs are expensed as incurred and consist primarily of personnel-related expenses (primarily including salaries, related benefits, and stock-based compensation) for the Company’s product development employees. Research and development expenses also include non-personnel-related expenses such as third-party services for product development and consulting expenses, depreciation expense related to equipment used in research and development activities, and allocation of the Company’s general overhead expenses. |
Advertising Cost | Advertising CostsAdvertising costs are charged to sales and marketing expense in the consolidated statements of operations as incurred. |
Stock-Based Compensation | Stock-Based Compensation The Company issues stock options and RSUs to employees, consultants and directors, and stock purchase rights granted under the 2021 Employee Stock Purchase Plan (ESPP) to employees based on the estimated fair value on the date of the grant. Stock-based compensation expense is recognized in the consolidated statements of operations on a straight-line basis over the requisite service period, which is the vesting period of the respective awards. Forfeitures are accounted for when they occur. The fair value of RSUs is based on the closing market price of its Class A common stock on the date of the grant. Prior to the IPO, the Company determined the fair value of the common stock underlying stock options and RSUs by considering numerous objective and subjective factors including, but not limited to: (i) independent third-party valuations, (ii) the prices, rights, preferences, and privileges of the Company’s redeemable convertible preferred stock relative to its common stock, (iii) the lack of marketability of the common stock, (iv) current business conditions and financial projections, and (iv) the likelihood of achieving an IPO or sale event. The fair values of stock options and the stock purchase rights under the ESPP are estimated using the Black-Scholes option-pricing model, which requires the input of highly subjective assumptions. These assumptions represent the Company's best estimates and involve inherent uncertainties and the application of the Company's judgement. The main assumptions used in the Black-Scholes option-pricing model include: Expected term— The expected term represents the period that stock-based awards are expected to be outstanding. The expected term for option grants is determined using the simplified method which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company considers this appropriate as there is not sufficient historical information available to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The expected term for ESPP is the length of time from the grant date to the date on which the stock is purchased by the employees. Stock price volatility— For the stock price volatility over the expected term of six months and one year, the Company estimates the stock price volatility using the combination of the average historical volatility of its own stock and those of comparable companies with similar characteristics to it. For expected term of greater than one year, since the Company's common stock lacks sufficient trading history, the stock price volatility over the expected term is estimated based on the average historical volatility of comparable companies with similar characteristics to those of the Company. Risk-free interest rate— The risk-free interest rate is based on the yield of the U.S. treasury debt securities commensurate with the expected term. Dividend yield— Since the Company has never paid and has no intention to pay cash dividends on its common stock, the dividend yield is zero. For the performance-based award granted to the CEO with both a service-based vesting condition and a market condition (as discussed further in Note 10— Stockholders' Equity and Stock-Based Compensation ), the Company determined the fair value of the award by using the Monte Carlo simulation model. The main assumptions used in the Monte Carlo simulation model include stock price volatility, risk-free interest rate, dividend yield and the measurement period, which is the period over which simulated stock prices of the Company are used to evaluate the possibility of achieving the specified stock price targets. Since both vesting conditions have to be met for each tranche of the award to ultimately vest, the associated stock-based compensation expense is recognized over the longer of the derived service period or the requisite service period, using the accelerated attribution method. Provided that the CEO remains employed by the Company in his current position, stock-based compensation expense is recognized over the requisite service period, regardless of whether the stock price goals are achieved. |
Income Taxes | Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December 31, 2022 and 2021, the Company has recorded a full valuation allowance against its U.S. deferred tax assets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is more likely than not of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. |
Cash and Cash Equivalents | Cash and Cash EquivalentsCash and cash equivalents consist of deposits held at financial institutions, money market funds, as well as highly liquid investments with an original maturity of three months or less when purchased. Cash and cash equivalents are recorded at cost, which approximates fair value. |
Marketable Securities | Marketable SecuritiesMarketable securities consist primarily of debt securities such as corporate bonds, commercial paper, U.S. treasury securities, and U.S. government agency securities. These securities are classified as available-for-sale securities at the time of purchase as they represent funds readily available for current operations, and the Company also has the ability and intent to liquidate them at any time to meet its operating cash needs, if necessary. All available-for-sale debt securities are recorded at their estimated fair value, with changes in fair value recognized as unrealized gains or losses in accumulated other comprehensive income. For available-for-sale debt securities in an unrealized loss position, the Company evaluates whether a current expected credit loss exists based on available information relevant to the credit rating of the security, current economic conditions and reasonable and supportable forecasts. Expected credit losses are recorded in other income (expense), net, on the consolidated statements of income, and any remaining unrealized losses are recognized in accumulated other comprehensive income or loss in the stockholders' equity section of the consolidated balance sheets. Realized gains and losses are determined based on the specific identification method and are reported in interest and other income, net in the consolidated statements of operations.Marketable securities also include mutual funds comprised of certain term bonds. These mutual funds meet certain criteria for equity investments in accordance with ASU 2016-01, Recognition and Measurement of Financial Assets and Liabilities. Under this guidance, the Company measures these mutual funds at their estimated fair value, with changes in fair value recognized in interest and other income, net in the consolidated statements of operations. |
Accounts Receivable and Allowance for Credit Losses | Accounts Receivable and Allowance for Credit LossesTrade accounts receivable are recorded at the invoiced amount, net of allowance for credit losses. The allowance is based on the Company’s assessment of the collectability of accounts and is recorded as an offset to revenue and deferred revenue. The Company regularly reviews the adequacy of the allowance by considering the age of each outstanding invoice and the collection history. |
Concentrations of Credit Risk | Concentrations of Credit Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash and cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the years ended December 31, 2022, 2021, and 2020 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of December 31, 2022 and 2021. The Company primarily relies upon Amazon Web Services (AWS) to provide its cloud computing infrastructure, serve customers and operate certain aspects of its services. Any disruption of AWS's services would impact the Company's operations and its business could be adversely impacted. |
Deferred Contract Acquisition Costs | Deferred Contract Acquisition Costs Deferred contract acquisition costs are incremental costs that are associated with acquiring customer contracts and consist primarily of sales commissions and the associated payroll taxes and certain referral fees paid to third-party resellers. The costs incurred upon the execution of initial and expansion contracts are primarily deferred and amortized over an expected benefit period of three years. The expected benefit period is determined by taking into consideration the Company’s contracts with customers, technology life cycle and other factors. The Company considers the expected benefit period to exceed the initial contract term for certain costs because of anticipated renewals and because sales commission rates for renewal contracts are not commensurate with sales commissions for initial contracts. The Company includes amortization of deferred commissions in sales and marketing expense in its consolidated statements of operations. There was no impairment loss in relation to the incremental selling costs capitalized for the years ended December 31, 2022, 2021, and 2020. |
Property and Equipment, net | Property and Equipment, net Property and equipment, net, including capitalized internally-developed software, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets as follows: Estimated Useful Life Computers 3 years Capitalized internal-use software 3 years Office equipment, furniture and fixtures 5 years Motor vehicles 5 years Leasehold improvements Lesser of lease term or 5 years |
Capitalized Internal-Use Software | Capitalized Internal-Use Software The Company capitalizes costs incurred in its software development projects as part of property and equipment during the application development stage. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Once the development project is available for general release, capitalization ceases, and the Company estimates the useful life of the asset and begins amortization. Internal-use software is amortized on a straight-line basis over its estimated useful life, which is generally three years. The Company also capitalizes certain costs related to its enterprise cloud computing services and certain projects for internal use incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Capitalized cloud computing costs are amortized on a straight-line basis over its estimated useful life. |
Long-Lived Assets (Including Goodwill and Intangible Assets) | Long-Lived Assets (Including Goodwill and Intangible Assets) Long-lived assets with finite lives include property and equipment, capitalized internal-use software, right-of-use (ROU) assets and acquired intangible assets. The Company evaluates long-lived assets, including acquired intangible assets and capitalized internal-use software, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds these estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group. |
Goodwill | Goodwill is not amortized but rather is tested for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. The Company elected to bypass the qualitative assessment, and performed a quantitative goodwill impairment test. Goodwill impairment is recognized when the quantitative assessment results in the carrying value of the reporting unit exceeding its fair value, in which case an impairment charge in the amount of such excess is recorded to goodwill, limited to the amount of goodwill. |
Net Loss per Share Attributable to Common Stockholders | Net Loss per Share Attributable to Common Stockholders Basic and diluted net loss per share attributable to common stockholders are presented in conformity with the two-class method required for participating securities. Under the two-class method, net income is attributed to common stockholders and participating securities based on their participation rights. Prior to the IPO, the Company considered all series of its redeemable convertible preferred stock to be participating securities. Net loss attributable to common stockholders was not allocated to the redeemable convertible preferred stock as the holders of the redeemable convertible preferred stock were not contractually obligated to share in the losses of the Company. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the number of weighted-average shares of common stock outstanding during the reporting period. Prior to the IPO, the net loss attributable to common stockholders was adjusted for accretion of the carrying value of redeemable convertible preferred stock and deemed dividend distribution. Since the Company has reported net losses for all periods presented, all potentially dilutive securities are considered antidilutive, and accordingly, diluted net loss per share is the same as basic net loss per share. |
Defined Benefit Plan | Defined Benefit Plan Employees in India are entitled to benefits under the Gratuity Act, a defined benefit retirement plan covering eligible employees. The plan requires employers to provide for a lump-sum payment to eligible employees at retirement, death, and incapacitation or on termination of employment, of an amount based on the respective employee’s salary and tenure of employment. Employees in India are also entitled to a defined benefit plan with benefits based on an employee’s accumulated leave balance and salary. Both plans are unfunded arrangements. Current service costs are accrued in the period to which they relate. The benefit obligations are calculated by a qualified actuary using the projected unit credit method and the unfunded position is recognized as a liability in the consolidated balance |
Leases | Leases The Company leases office space under operating leases with expiration dates through 2031. The Company determines whether an arrangement constitutes a lease and records lease liabilities and ROU assets on its consolidated balance sheets at the lease commencement date. Lease liabilities are measured based on the present value of the total lease payments not yet paid, discounted based on either the rate implicit in the lease or the Company's incremental borrowing rate (the estimated rate the Company would be required to pay for a collateralized borrowing equal to the total lease payments over the term of the lease), whichever is more readily determinable. The incremental borrowing rate is based on an estimate of the Company's expected unsecured borrowing rate for its notes, adjusted for tenor and collateralized security features. Lease liabilities due within 12 months are included within accrued liabilities on the Company's consolidated balance sheets. ROU assets are measured based on the corresponding lease liability adjusted for (i) payments made to the lessor at or before the lease commencement date, (ii) initial direct costs incurred, and (iii) tenant incentives received, incurred or payable under the lease. Recognition of rent expense begins when the lessor makes the underlying asset available to the Company. The Company does not assume renewals or early terminations of its leases unless it is reasonably certain to exercise these options at commencement and does not allocate consideration between lease and non-lease components. For short-term leases, the Company records rent expense in its consolidated statements of operations on a straight-line basis over the lease term and records variable lease payments as incurred. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Accounting Standards Adopted In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize most leases on their balance sheets as ROU assets with corresponding lease liabilities and eliminates certain real estate-specific provisions. The Company adopted this standard effective January 1, 2022 on a modified retrospective basis, and as such, results in comparative periods were not restated. As a result of the adoption, the Company recognized operating ROU assets of $24.3 million and operating lease liabilities of $28.8 million in its consolidated balance sheets on the adoption date. The Company has elected certain available practical expedients, which allow it to forego the reassessments of (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. The Company has also elected to combine lease and non-lease components for commercial lease arrangements. Additionally, the Company elected not to recognize operating ROU assets and the associated operating lease liabilities for leases with a term of 12 months or less from the lease commencement date. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets by requiring an allowance to be recorded as an offset to the amortized cost of such assets. The standard primarily impacts the amortized cost of the Company's available-for-sale debt securities. The Company adopted this standard on January 1, 2022 using the modified retrospective approach, which did not result in a material impact on its consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). The standard eliminates certain exceptions related to the approach for intraperiod tax allocation and the methodology for calculating income taxes in an interim period. The standard also simplifies aspects of accounting for franchise taxes and enacted changes in tax or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis for goodwill. The Company adopted this standard effective January 1, 2022, which did not result in a material impact on its consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires acquiring entities to apply Topic 606 to recognize and |
Fair Value Measurements | The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Useful Lives of Property, Plant and Equipment | Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets as follows: Estimated Useful Life Computers 3 years Capitalized internal-use software 3 years Office equipment, furniture and fixtures 5 years Motor vehicles 5 years Leasehold improvements Lesser of lease term or 5 years The following table summarizes property and equipment, net as of December 31, 2022 and 2021 (in thousands): December 31, 2022 2021 Computers $ 16,552 $ 13,041 Capitalized internal-use software 20,230 14,178 Office equipment 3,744 3,375 Furniture and fixtures 8,881 8,395 Motor vehicles 1,158 1,421 Leasehold improvements 5,654 4,274 Construction in progress 224 — Total property and equipment 56,443 44,684 Less: accumulated depreciation and amortization (32,304) (23,206) Property and equipment, net $ 24,139 $ 21,478 |
Revenue from Contracts with C_2
Revenue from Contracts with Customers (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table summarizes revenue by the Company’s service offerings (in thousands): Year Ended December 31, 2022 2021 2020 Subscription services $ 485,322 $ 360,506 $ 242,879 Professional services 12,677 10,516 6,780 Total revenue $ 497,999 $ 371,022 $ 249,659 |
Deferred Revenue and Remaining Performance Obligations | The following table summarizes the changes in the balance of deferred revenue during the years (in thousands): Year Ended December 31, 2022 2021 2020 Balance at beginning of the year $ 160,173 $ 104,184 $ 67,540 Add: Billings during the year 543,452 427,011 286,303 Less: Revenue recognized during the year (497,999) (371,022) (249,659) Balance at end of the year $ 205,626 $ 160,173 $ 104,184 |
Deferred Contract Acquisition Costs | The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Year Ended December 31, 2022 2021 2020 Balance at beginning of the year $ 29,647 $ 18,273 $ 11,610 Add: Contract costs capitalized during the year 28,560 24,218 14,344 Less: Amortization of contract costs during the year (18,532) (12,844) (7,681) Balance at end of the year $ 39,675 $ 29,647 $ 18,273 |
Cash Equivalents and Marketab_2
Cash Equivalents and Marketable Securities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Available-for-Sale Securities Reconciliation | Cash equivalents and available-for-sale debt securities consisted of the following as of December 31, 2022 and 2021 (in thousands): December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 219,512 $ — $ — $ 219,512 U.S. treasury securities 13,912 3 — 13,915 U.S. government agency securities 10,417 2 — 10,419 Corporate debt securities 1,995 1 — 1,996 Total cash equivalents 245,836 6 — 245,842 Debt securities: U.S. treasury securities 441,909 36 (3,160) 438,785 U.S. government agency securities 301,009 35 (3,531) 297,513 Corporate debt securities 106,436 — (817) 105,619 Total debt securities 849,354 71 (7,508) 841,917 Total cash equivalents and debt securities $ 1,095,190 $ 77 $ (7,508) $ 1,087,759 December 31, 2021 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 684,485 $ — $ — $ 684,485 U.S. treasury securities 22,000 — — 22,000 U.S. government agency securities 4,286 — (1) 4,285 Corporate debt securities 15,998 — — 15,998 Total cash equivalents 726,769 — (1) 726,768 Debt securities: U.S. treasury securities 442,715 2 (432) 442,285 U.S. government agency securities 75,725 — (159) 75,566 Corporate debt securities 54,335 17 (175) 54,177 Total debt securities 572,775 19 (766) 572,028 Total cash equivalents and debt securities $ 1,299,544 $ 19 $ (767) $ 1,298,796 |
Schedule of Available-for-Sale, Unrealized Loss Position, Fair Value | The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of December 31, 2022 (in thousands): December 31, 2022 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 190,820 $ (1,794) $ 105,115 $ (1,366) $ 295,935 $ (3,160) U.S. government agency securities 220,766 (2,245) 42,754 (1,286) 263,520 (3,531) Corporate debt securities 30,485 (455) 22,864 (362) 53,349 (817) Total $ 442,071 $ (4,494) $ 170,733 $ (3,014) $ 612,804 $ (7,508) |
Schedule of Amortized Costs and Fair Value of Debt Securities Based on Contractual Maturities | The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): December 31, 2022 Amortized Cost Fair Value Due within one year $ 608,359 $ 604,039 Due after one year but within five years 240,995 237,878 Total $ 849,354 $ 841,917 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of December 31, 2022 and 2021 (in thousands): December 31, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 219,512 $ — $ 219,512 U.S. treasury securities 13,915 — 13,915 U.S. government agency securities — 10,419 10,419 Corporate debt securities — 1,996 1,996 Marketable securities: U.S. treasury securities 438,785 — 438,785 U.S. government agency securities — 297,513 297,513 Corporate debt securities — 105,619 105,619 Term bond mutual funds — 1,488 1,488 Total financial assets $ 672,212 $ 417,035 $ 1,089,247 December 31, 2021 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 684,485 $ — $ 684,485 U.S. treasury securities 22,000 — 22,000 U.S. government agency securities — 4,285 4,285 Corporate debt securities — 15,998 15,998 Marketable securities: U.S. treasury securities 442,285 — 442,285 U.S. government agency securities — 75,566 75,566 Corporate debt securities — 54,177 54,177 Term bond mutual funds — 3,651 3,651 Total financial assets $ 1,148,770 $ 153,677 $ 1,302,447 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Property, Plant and Equipment | Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets as follows: Estimated Useful Life Computers 3 years Capitalized internal-use software 3 years Office equipment, furniture and fixtures 5 years Motor vehicles 5 years Leasehold improvements Lesser of lease term or 5 years The following table summarizes property and equipment, net as of December 31, 2022 and 2021 (in thousands): December 31, 2022 2021 Computers $ 16,552 $ 13,041 Capitalized internal-use software 20,230 14,178 Office equipment 3,744 3,375 Furniture and fixtures 8,881 8,395 Motor vehicles 1,158 1,421 Leasehold improvements 5,654 4,274 Construction in progress 224 — Total property and equipment 56,443 44,684 Less: accumulated depreciation and amortization (32,304) (23,206) Property and equipment, net $ 24,139 $ 21,478 |
Schedule of Accrued Liabilities | The following table summarizes accrued liabilities as of December 31, 2022 and 2021 (in thousands): December 31, 2022 2021 Accrued compensation $ 20,192 $ 17,261 Accrued third-party cloud infrastructure expenses 2,752 2,785 Accrued reseller commissions 7,731 5,870 Accrued advertising and marketing expenses 4,465 6,022 Advanced payments from customers 3,480 3,260 Accrued taxes 7,730 10,777 Operating lease liabilities, current 6,775 — Contributions withheld for employee stock purchase plan 1,546 4,211 Other accrued expenses 4,337 5,643 Total accrued liabilities $ 59,008 $ 55,829 |
Business Combination, Asset P_2
Business Combination, Asset Purchase and Intangible Assets, Net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Finite-Lived Intangible Assets | The following tables summarize acquired intangible assets as of December 31, 2022 and 2021 (amounts in thousands): December 31, 2022 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (in years) Developed technology $ 10,496 $ (10,338) $ 158 0.2 Customer relationships 1,600 (1,455) 145 0.4 Total $ 12,096 $ (11,793) $ 303 December 31, 2021 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (in years) Developed technology $ 10,496 $ (9,147) $ 1,349 0.9 Customer relationships 1,600 (1,055) 545 1.4 Total $ 12,096 $ (10,202) $ 1,894 |
Finite-lived Intangible Assets Amortization Expense | Total amortization of acquired intangible assets for the years ended December 31, 2022, 2021, and 2020 is as follows (in thousands): Year Ended December 31, 2022 2021 2020 Developed technology Cost of revenue $ 1,191 $ 3,929 $ 3,867 Customer relationships: Sales and marketing $ 400 400 401 Total amortization expense $ 1,591 $ 4,329 $ 4,268 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Lease, Cost | The following table presents various components of the lease costs (in thousands): Operating Leases December 31, 2022 Operating lease cost $ 8,312 Short-term lease cost 1,162 Variable lease cost 2,797 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate December 31, 2022 Weighted-average remaining lease term (in years) 4.81 Weighted-average discount rate 7.4 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Year Ended Supplemental Cash Flow Information: December 31, 2022 Cash payments included in the measurement of operating lease liabilities $ 8,885 Operating ROU assets obtained in exchange for lease obligations 14,903 |
Lessee, Operating Lease, Liability, Maturity | Maturities of the operating lease liabilities are as follows (in thousands): Year Ending December 31: Operating Leases 2023 $ 9,186 2024 9,715 2025 8,759 2026 5,499 2027 4,206 Thereafter 5,760 Total lease payments 43,125 Less: imputed interest (8,176) Present value of operating lease liabilities $ 34,949 Future minimum lease payments under non-cancelable operating leases as of December 31, 2021, were as follows (in thousands): Year ending December 31, Operating Leases 2022 $ 6,954 2023 6,790 2024 6,642 2025 5,976 2026 3,579 Thereafter 4,304 Total minimum future payments $ 34,245 |
Commitment and Contingencies (T
Commitment and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Future Minimum Payments Under the Company’s Non-cancelable Purchase Commitments | Future minimum payments under the Company’s non-cancelable purchase commitments as of December 31, 2022 are presented in the table below (in thousands): Year ending December 31, Contractual Commitments 2023 $ 46,191 2024 46,965 2025 11,982 Total $ 105,138 |
Stockholders' Equity and Stoc_2
Stockholders' Equity and Stock Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Schedule of Unrealized Gains or Losses Within Accumulated Other Comprehensive Income (Loss) | The following tables shows the change in unrealized gains or losses within accumulated other comprehensive (loss) income: Year Ended December 31, 2022 2021 2020 Beginning balance $ (747) $ 411 $ 139 Unrealized (losses) gains on available-for-sale debt securities (6,684) (1,152) 405 Reclassification of unrealized gains to interest and other income, net, in the consolidated statements of operations — (6) (133) Net impact to other comprehensive (loss) income in current period (6,684) (1,158) 272 Ending balance $ (7,431) $ (747) $ 411 |
Summary of Common Shares Reserved for Future Issuance | Shares of common stock reserved for future issuance were as follows (in thousands): December 31, 2022 2011 Stock Plan: Options and RSUs outstanding 21,380 2021 Equity Incentive Plan: RSUs outstanding 10,122 Shares reserved for future award issuances 52,178 2022 Inducement Plan: Options and RSUs outstanding 3,509 Shares reserved for future award issuances 6,491 2021 Employee Stock Purchase Plan 8,371 Total shares of common stock reserved for issuance 102,051 |
Summary of Valuation Assumptions of Employee Stock Purchase Plan | The following table summarizes the range of valuation assumptions used in estimating the fair value of the ESPP during the period: Year Ended December 31, Valuation Assumption Inputs 2022 2021 Expected term (in years) 0.5 - 2.0 0.6 - 2.1 Stock price volatility 55.8% - 84.5% 47.7% - 58.5% Risk-free interest rate 1.54% - 4.62% 0.06% - 0.29% Dividend yield 0.00% 0.00% |
Schedule of Stock Option Activity | Stock option activity during the year ended December 31, 2022 is as follows (in thousands, except per share data): Share Information: Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (1) Balance as of December 31, 2021 1,348 $ 0.27 3.6 $ 35,020 Stock options granted 1,816 $ 13.61 Stock options exercised (406) $ 0.27 Stock options cancelled / forfeited / expired — $ — Balance as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Options vested and expected to vest as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Options exercisable as of December 31, 2022 942 $ 0.27 2.7 $ 13,598 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested. |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | The following table summarizes the valuation assumptions used in estimating the fair value of stock options granted during the year: Year Ended December 31, Valuation Assumption Inputs 2022 Expected term (in years) 6.1 Stock price volatility 65.0% Risk-free interest rate 3.37% Dividend yield —% |
Schedule of Restricted Stock Unit Activity | RSU activity, which includes PRSUs, during the year ended December 31, 2022 is as follows (in thousands, except per share data): Share Information: Number of Shares Weighted-Average Grant Date Fair Value Unvested, as of December 31, 2021 47,830 $ 14.47 Granted 13,054 $ 16.88 Vested (1) (24,397) $ 9.63 Forfeited (4,234) $ 16.24 Unvested, as of December 31, 2022 32,253 $ 18.86 |
Summary of Valuation Assumptions, CEO Performance Award | The valuation assumptions using the Monte Carlo simulation model at the date of grant were: Valuation Assumption Inputs Measurement period (in years) 7.0 Stock price volatility 60.0% Risk-free interest rate 1.12% Dividend yield —% |
Stock-based Compensation Expense | Total stock-based compensation expense recorded for the years ended December 31, 2022, 2021, and 2020 was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Equity awards: Cost of revenue $ 7,039 $ 5,604 $ — Research and development (1) 36,413 45,162 8 Sales and marketing (2) 64,328 53,169 7 General and administrative (3) 99,916 69,508 29 Total employee awards 207,696 173,443 44 Secondary transaction — — 43,236 Stock-based compensation, net of amounts capitalized 207,696 173,443 43,280 Capitalized stock-based compensation 1,665 585 — Total stock-based compensation expense $ 209,361 $ 174,028 $ 43,280 (1) Stock-based compensation expense recorded to research and development in the consolidated statements of operations excludes amounts that were capitalized for internal-use software for the years ended December 31, 2022 and 2021. (2) Sales and marketing expense for the year ended December 31, 2022 includes $3.2 million of stock-based compensation expense associated with RSU and options granted to the President in September 2022. (3) General and administrative expense includes $55.9 million and $19.1 million of stock-based compensation expense associated with RSUs and PRSUs primarily granted to the CEO in September 2021 for the years ended December 31, 2022 and 2021, respectively. |
Share-Based Payment Arrangement, Nonvested Award, Cost | As of December 31, 2022, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): December 31, 2022 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense (in years) RSUs and PSUs $ 531,758 3.0 Stock options 13,758 3.7 ESPP 12,606 1.1 Total unrecognized stock-based compensation expense $ 558,122 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Numerator: Net loss $ (232,132) $ (191,995) $ (57,294) Accretion of redeemable convertible preferred stock — (2,646,662) (1,560,524) Net loss attributable to Class A and Class B common stockholders - basic and diluted $ (232,132) $ (2,838,657) $ (1,617,818) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 284,587 130,652 76,945 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.82) $ (21.73) $ (21.03) |
Schedule of Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share | The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Year Ended December 31, 2022 2021 2020 Redeemable convertible preferred stock — — 153,938 RSUs and PRSUs 32,253 47,830 33,928 Stock options 2,758 1,348 2,096 ESPP 124 160 — Total 35,135 49,338 189,962 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income before Income Tax, Domestic and Foreign | The Company’s net loss before provision for income taxes for the years ended December 31, 2022, 2021, and 2020 was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Domestic $ (252,261) $ (211,844) $ (69,102) Foreign 31,471 30,365 15,823 Total $ (220,790) $ (181,479) $ (53,279) |
Schedule of Components of the Provision for Income Taxes | The components of the provision for income taxes for the years ended December 31, 2022, 2021, and 2020 were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Current: Domestic $ 2,137 $ 2,876 $ (12) Foreign 11,610 9,547 6,387 Deferred: Domestic — — — Foreign (2,405) (1,907) (2,360) Total provision for income taxes $ 11,342 $ 10,516 $ 4,015 |
Schedule of Effective Income Tax Rate Reconciliation | The following is a reconciliation of the federal statutory income tax rate to the Company’s effective tax rate for the years ended December 31, 2022, 2021, and 2020: Year Ended December 31, 2022 2021 2020 Federal income tax 21.0 % 21.0 % 21.0 % Stock-based compensation (1.6) 2.1 (17.1) Change in valuation allowance (22.4) (25.4) (11.8) Earnings from foreign subsidiaries (1.2) (0.5) (1.3) Other items (0.9) (3.0) 1.6 Total provision for income taxes (5.1) % (5.8) % (7.6) % |
Schedule of Deferred Tax Assets and Liabilities | The components of the Company’s net deferred tax assets as of December 31, 2022 and 2021, were as follows (in thousands): December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 100,090 $ 78,077 Foreign tax credit carryforwards 4,955 4,955 Capitalized R&E under IRC 174 36,970 — Stock-based compensation 4,337 9,643 Accruals and Reserves 9,032 6,584 Depreciation and amortization 1,449 1,633 Allowance for uncollectible accounts 212 66 Operating lease liability 19,207 — Total deferred tax assets 176,252 100,958 Less: valuation allowance (146,134) (89,903) Deferred tax assets, net of valuation allowance 30,118 11,055 Deferred tax liabilities: Commissions (6,146) (4,771) Operating lease right-of-use assets (15,283) — Net deferred tax assets $ 8,689 $ 6,284 |
Schedule of Unrecognized Tax Benefits | The following table presents a reconciliation of the beginning and ending amount of the unrecognized tax benefits (in thousands): Year Ended December 31, 2022 2021 Unrecognized gross tax benefits at the beginning of the period $ 2,227 $ — Increases related to prior year tax positions — 1,269 Decreases related to prior year tax positions (6) — Increases in current year unrecognized benefits 1,426 958 Unrecognized gross tax benefits at the end of the period $ 3,647 $ 2,227 |
Geographic Information (Tables)
Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Revenue and Long-Lived Assets by Geographical Region | The following table summarizes revenue by geographic region (in thousands): Year Ended December 31, 2022 2021 2020 North America $ 216,112 $ 160,224 $ 111,644 Europe, Middle East and Africa 193,899 152,542 98,992 Asia Pacific 74,948 49,933 33,445 Other 13,040 8,323 5,578 Total revenue $ 497,999 $ 371,022 $ 249,659 December 31, 2022 2021 North America $ 23,839 $ 13,780 Europe, Middle East and Africa 4,039 578 Asia Pacific 29,285 9,015 Total long-lived assets $ 57,163 $ 23,373 |
Description of Business (Detail
Description of Business (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2021 USD ($) $ / shares shares | Dec. 31, 2021 shares | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) shares | Dec. 31, 2020 USD ($) | |
Sale of Stock [Line Items] | |||||
Proceeds from initial public offering, net of underwriting discounts | $ | $ 1,100,000 | $ 0 | $ 1,069,348 | $ 0 | |
Deferred offering costs reclassified to stockholders' equity (deficit) | $ | $ 7,300 | ||||
Number of shares issued in conversion (in shares) | 1 | ||||
Number of shares issued for each vested RSU (in shares) | 1 | ||||
Stock split ratio, common stock | 10 | ||||
Common Stock | |||||
Sale of Stock [Line Items] | |||||
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) | 153,937,730 | 153,938,000 | |||
IPO | |||||
Sale of Stock [Line Items] | |||||
Public offering price (in USD per share) | $ / shares | $ 36 | ||||
IPO | Class A Common Stock | |||||
Sale of Stock [Line Items] | |||||
Number of shares issued and sold (in shares) | 31,350,000 | ||||
Over-Allotment Option | |||||
Sale of Stock [Line Items] | |||||
Number of shares issued and sold (in shares) | 2,850,000 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Narrative (Details) | 12 Months Ended | |||
Dec. 31, 2022 USD ($) segment | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | Jan. 01, 2022 USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of operating segments | segment | 1 | |||
Advertising costs | $ 47,200,000 | $ 41,200,000 | $ 31,100,000 | |
Dividend yield | 0% | |||
Credit loss on available-for-sale debt securities | $ 0 | 0 | 0 | |
Capitalized contract costs, amortization period | 3 years | |||
Impairment loss on incremental selling costs capitalized | $ 0 | 0 | 0 | |
Impairment of goodwill | 0 | 0 | $ 0 | |
Plan benefit obligation | 9,600,000 | 7,400,000 | ||
Liability, defined benefit plan, noncurrent | 8,600,000 | 6,700,000 | ||
Liability, defined benefit plan, current | 1,000,000 | $ 700,000 | ||
Operating lease right-of-use assets | 33,024,000 | |||
Operating lease liabilities | $ 34,949,000 | |||
Accounting Standards Update 2016-02 | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Operating lease right-of-use assets | $ 24,300,000 | |||
Operating lease liabilities | $ 28,800,000 | |||
Capitalized internal-use software | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Estimated useful life | 3 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Property and Equipment (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Computers | |
Property, Plant and Equipment [Line Items] | |
Estimated Useful Life | 3 years |
Capitalized internal-use software | |
Property, Plant and Equipment [Line Items] | |
Estimated Useful Life | 3 years |
Office equipment, furniture and fixtures | |
Property, Plant and Equipment [Line Items] | |
Estimated Useful Life | 5 years |
Motor vehicles | |
Property, Plant and Equipment [Line Items] | |
Estimated Useful Life | 5 years |
Leasehold improvements | |
Property, Plant and Equipment [Line Items] | |
Estimated Useful Life | 5 years |
Revenue from Contracts with C_3
Revenue from Contracts with Customers - Disaggregation of Revenues (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 497,999 | $ 371,022 | $ 249,659 |
Subscription services | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | 485,322 | 360,506 | 242,879 |
Professional services | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 12,677 | $ 10,516 | $ 6,780 |
Revenue from Contracts with C_4
Revenue from Contracts with Customers - Changes in the Balance of Deferred Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Changes in the Balance of Deferred Revenue [Roll Forward] | |||
Balance at beginning of the year | $ 160,173 | $ 104,184 | $ 67,540 |
Add: Billings during the year | 543,452 | 427,011 | 286,303 |
Less: Revenue recognized during the year | (497,999) | (371,022) | (249,659) |
Balance at end of the year | $ 205,626 | $ 160,173 | $ 104,184 |
Revenue from Contracts with C_5
Revenue from Contracts with Customers - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |||
Revenue recognized during the period | $ 158.7 | $ 103.8 | $ 67.5 |
Remaining performance obligation | 301.5 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |||
Remaining performance obligation | $ 234.7 | ||
Remaining performance obligation, expected timing of satisfaction, period | 12 months |
Revenue from Contracts with C_6
Revenue from Contracts with Customers - Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Change in Deferred Contract Acquisition Costs [Roll Forward] | |||
Balance at beginning of the year | $ 29,647 | $ 18,273 | $ 11,610 |
Add: Contract costs capitalized during the year | 28,560 | 24,218 | 14,344 |
Less: Amortization of contract costs during the year | (18,532) | (12,844) | (7,681) |
Balance at end of the year | $ 39,675 | $ 29,647 | $ 18,273 |
Cash Equivalents and Marketab_3
Cash Equivalents and Marketable Securities - Schedule of Carrying Amounts and Fair Values of Debt Securities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Unrealized Gains | $ 77 | $ 19 |
Unrealized Losses | (7,508) | (767) |
Cash Equivalents And Available-For-Sale Debt Securities [Abstract] | ||
Amortized Cost | 1,095,190 | 1,299,544 |
Fair Value | 1,087,759 | 1,298,796 |
Cash equivalents | ||
Debt Securities, Available-for-sale [Line Items] | ||
Unrealized Gains | 6 | 0 |
Unrealized Losses | 0 | (1) |
Cash Equivalents And Available-For-Sale Debt Securities [Abstract] | ||
Amortized Cost | 245,836 | 726,769 |
Fair Value | 245,842 | 726,768 |
Cash equivalents | Money market funds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cash Equivalents | 219,512 | 684,485 |
Cash equivalents | U.S. treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 13,912 | 22,000 |
Unrealized Gains | 3 | 0 |
Unrealized Losses | 0 | 0 |
Fair Value | 13,915 | 22,000 |
Cash equivalents | U.S. government agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 10,417 | 4,286 |
Unrealized Gains | 2 | 0 |
Unrealized Losses | 0 | (1) |
Fair Value | 10,419 | 4,285 |
Cash equivalents | Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 1,995 | 15,998 |
Unrealized Gains | 1 | 0 |
Unrealized Losses | 0 | 0 |
Fair Value | 1,996 | 15,998 |
Debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 849,354 | 572,775 |
Unrealized Gains | 71 | 19 |
Unrealized Losses | (7,508) | (766) |
Fair Value | 841,917 | 572,028 |
Debt securities | U.S. treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 441,909 | 442,715 |
Unrealized Gains | 36 | 2 |
Unrealized Losses | (3,160) | (432) |
Fair Value | 438,785 | 442,285 |
Debt securities | U.S. government agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 301,009 | 75,725 |
Unrealized Gains | 35 | 0 |
Unrealized Losses | (3,531) | (159) |
Fair Value | 297,513 | 75,566 |
Debt securities | Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Total | 106,436 | 54,335 |
Unrealized Gains | 0 | 17 |
Unrealized Losses | (817) | (175) |
Fair Value | $ 105,619 | $ 54,177 |
Cash Equivalents and Marketab_4
Cash Equivalents and Marketable Securities - Schedule of Continuous Unrealized Loss Position and Fair Values of Debt Securities (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Fair Value | |
Less than 12 months | $ 442,071 |
Greater than 12 months | 170,733 |
Total | 612,804 |
Unrealized Loss | |
Less than 12 months | (4,494) |
Greater than 12 months | (3,014) |
Total | (7,508) |
U.S. treasury securities | |
Fair Value | |
Less than 12 months | 190,820 |
Greater than 12 months | 105,115 |
Total | 295,935 |
Unrealized Loss | |
Less than 12 months | (1,794) |
Greater than 12 months | (1,366) |
Total | (3,160) |
U.S. government agency securities | |
Fair Value | |
Less than 12 months | 220,766 |
Greater than 12 months | 42,754 |
Total | 263,520 |
Unrealized Loss | |
Less than 12 months | (2,245) |
Greater than 12 months | (1,286) |
Total | (3,531) |
Corporate debt securities | |
Fair Value | |
Less than 12 months | 30,485 |
Greater than 12 months | 22,864 |
Total | 53,349 |
Unrealized Loss | |
Less than 12 months | (455) |
Greater than 12 months | (362) |
Total | $ (817) |
Cash Equivalents and Marketab_5
Cash Equivalents and Marketable Securities - Amortized Cost and Fair Value Based on Contractual Maturities (Details) - Marketable Securities $ in Thousands | Dec. 31, 2022 USD ($) |
Amortized Cost | |
Due within one year | $ 608,359 |
Due after one year but within five years | 240,995 |
Total | 849,354 |
Fair Value | |
Due within one year | 604,039 |
Due after one year but within five years | 237,878 |
Total | $ 841,917 |
Cash, Cash Equivalents and Mark
Cash, Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | ||
Sep. 30, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Debt Securities, Available-for-sale [Line Items] | ||||
Accrued interest | $ 2,800 | |||
Sale of non-marketable equity investment | $ 24,000 | 0 | $ 23,979 | $ 0 |
Gain on sale of investment | $ 23,800 | $ 0 | 23,836 | $ 132 |
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current, Statement of Financial Position [Extensible Enumeration] | Prepaid expenses and other current assets | |||
Mutual funds | ||||
Debt Securities, Available-for-sale [Line Items] | ||||
Equity securities | $ 1,500 | $ 3,700 |
Fair Value Measurements - Asset
Fair Value Measurements - Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total financial assets | $ 1,089,247 | $ 1,302,447 |
U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 438,785 | 442,285 |
U.S. government agency securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 297,513 | 75,566 |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 105,619 | 54,177 |
Term bond mutual funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 1,488 | 3,651 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 219,512 | 684,485 |
U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 13,915 | 22,000 |
U.S. government agency securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 10,419 | 4,285 |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 1,996 | 15,998 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total financial assets | 672,212 | 1,148,770 |
Level 1 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 438,785 | 442,285 |
Level 1 | U.S. government agency securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 0 | 0 |
Level 1 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 0 | 0 |
Level 1 | Term bond mutual funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 0 | 0 |
Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 219,512 | 684,485 |
Level 1 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 13,915 | 22,000 |
Level 1 | U.S. government agency securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 0 | 0 |
Level 1 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 0 | 0 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total financial assets | 417,035 | 153,677 |
Level 2 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 0 | 0 |
Level 2 | U.S. government agency securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 297,513 | 75,566 |
Level 2 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 105,619 | 54,177 |
Level 2 | Term bond mutual funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 1,488 | 3,651 |
Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 0 | 0 |
Level 2 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 0 | 0 |
Level 2 | U.S. government agency securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | 10,419 | 4,285 |
Level 2 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents: | $ 1,996 | $ 15,998 |
Balance Sheet Components - Prop
Balance Sheet Components - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 56,443 | $ 44,684 |
Less: accumulated depreciation and amortization | (32,304) | (23,206) |
Property and equipment, net | 24,139 | 21,478 |
Computers | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 16,552 | 13,041 |
Capitalized internal-use software | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 20,230 | 14,178 |
Office equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 3,744 | 3,375 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 8,881 | 8,395 |
Motor vehicles | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 1,158 | 1,421 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 5,654 | 4,274 |
Construction in progress | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 224 | $ 0 |
Balance Sheet Components - Narr
Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Capitalized costs associated with internal-use software | $ 6.8 | $ 4.1 | $ 4.6 |
Amortization expense of capitalized internal-use software | 3.2 | 2.5 | 1.5 |
Net carrying value of capitalized internal-use software | 11.2 | 8.3 | |
Depreciation expense | 6.7 | 6.5 | $ 5.4 |
Compensation liabilities, noncurrent | $ 23.3 | $ 14.9 |
Balance Sheet Components - Accr
Balance Sheet Components - Accrued and Other Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accrued compensation | $ 20,192 | $ 17,261 |
Accrued third-party cloud infrastructure expenses | 2,752 | 2,785 |
Accrued reseller commissions | 7,731 | 5,870 |
Accrued advertising and marketing expenses | 4,465 | 6,022 |
Advanced payments from customers | 3,480 | 3,260 |
Accrued taxes | 7,730 | 10,777 |
Operating lease liabilities, current | 6,775 | |
Contributions withheld for employee stock purchase plan | 1,546 | 4,211 |
Other accrued expenses | 4,337 | 5,643 |
Total accrued liabilities | $ 59,008 | $ 55,829 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Total accrued liabilities |
Business Combination, Asset P_3
Business Combination, Asset Purchase and Intangible Assets, Net - Summary of Acquired Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | $ 12,096 | $ 12,096 |
Accumulated Amortization | (11,793) | (10,202) |
Net Carrying Value | 303 | 1,894 |
Developed technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | 10,496 | 10,496 |
Accumulated Amortization | (10,338) | (9,147) |
Net Carrying Value | $ 158 | $ 1,349 |
Weighted Average Remaining Useful Life | 2 months 12 days | 10 months 24 days |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Amount | $ 1,600 | $ 1,600 |
Accumulated Amortization | (1,455) | (1,055) |
Net Carrying Value | $ 145 | $ 545 |
Weighted Average Remaining Useful Life | 4 months 24 days | 1 year 4 months 24 days |
Business Combination, Asset P_4
Business Combination, Asset Purchase and Intangible Assets, Net - Summary of Acquired Intangible Assets Amortization Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of acquired intangible assets | $ 1,591 | $ 4,329 | $ 4,268 |
Developed technology | Cost of revenue | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of acquired intangible assets | 1,191 | 3,929 | 3,867 |
Customer relationships | Sales and marketing | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of acquired intangible assets | $ 400 | $ 400 | $ 401 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2022 | |
Lessee, Lease, Description [Line Items] | |||
Operating lease, option to extend, term | 6 years | ||
Rent expense | $ 9.7 | $ 10.2 | |
Minimum | |||
Lessee, Lease, Description [Line Items] | |||
Operating lease, term | 1 year | ||
Maximum | |||
Lessee, Lease, Description [Line Items] | |||
Operating lease, term | 8 years |
Leases - Schedule of Lease Cost
Leases - Schedule of Lease Cost (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Leases [Abstract] | |
Operating lease cost | $ 8,312 |
Short-term lease cost | 1,162 |
Variable lease cost | $ 2,797 |
Leases - Summary of Lease Term
Leases - Summary of Lease Term and Discount Rate (Details) | Dec. 31, 2022 |
Leases [Abstract] | |
Weighted-average remaining lease term (in years) | 4 years 9 months 21 days |
Weighted average discount rate (as a percent) | 7.40% |
Leases - Summary of Supplementa
Leases - Summary of Supplemental Cash Flow Information (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Leases [Abstract] | |
Cash payments included in the measurement of operating lease liabilities | $ 8,885 |
Operating lease right-of-use assets obtained in exchange for operating lease obligations | $ 14,903 |
Leases - Schedule of Maturities
Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Leases [Abstract] | |
2023 | $ 9,186 |
2024 | 9,715 |
2025 | 8,759 |
2026 | 5,499 |
2027 | 4,206 |
Thereafter | 5,760 |
Total minimum future payments | 43,125 |
Less: imputed interest | (8,176) |
Operating lease liabilities | $ 34,949 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands | Dec. 31, 2021 USD ($) |
Leases [Abstract] | |
2022 | $ 6,954 |
2023 | 6,790 |
2024 | 6,642 |
2025 | 5,976 |
2026 | 3,579 |
Thereafter | 4,304 |
Total minimum future payments | $ 34,245 |
Commitment and Contingencies (D
Commitment and Contingencies (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2023 | $ 46,191 |
2024 | 46,965 |
2025 | 11,982 |
Total | $ 105,138 |
Stockholders' Equity and Stoc_3
Stockholders' Equity and Stock Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||
Sep. 30, 2022 shares | Sep. 30, 2021 USD ($) target tranche $ / shares shares | Jan. 31, 2020 USD ($) shares | May 31, 2019 shares | Dec. 31, 2022 USD ($) vote $ / shares shares | Dec. 31, 2022 USD ($) purchasePeriod vote $ / shares shares | Dec. 31, 2021 USD ($) shares | Dec. 31, 2020 USD ($) shares | Aug. 31, 2022 shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Total shares of common stock reserved for issuance (in shares) | shares | 102,051,000 | 102,051,000 | |||||||
Stock options granted (in shares) | shares | 1,816,000 | 0 | 0 | ||||||
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes (in shares) | shares | 822,423 | 0 | |||||||
Contributions withheld for employee stock purchase plan | $ 1,546 | $ 1,546 | $ 4,211 | ||||||
Share-based payment arrangement, expensed and capitalized, amount | 209,361 | 174,028 | $ 43,280 | ||||||
Intrinsic value of option exercised | $ 5,900 | 14,000 | 9,800 | ||||||
Weighted average grant date fair value (in USD per share) | $ / shares | $ 8.26 | ||||||||
Stock withheld for tax withholding requirements (in shares) | shares | 9,800,000 | ||||||||
Stock-based compensation expense | $ 207,696 | 173,443 | 43,280 | ||||||
Secondary transaction | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | 43,200 | ||||||||
Sale of stock, consideration received on transaction | $ 25,500 | ||||||||
Fair value of shares | 14,700 | ||||||||
Secondary transaction | General and administrative | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | $ 10,800 | 10,800 | |||||||
Secondary Transaction - Repurchase of Common Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | 32,400 | ||||||||
Secondary Transaction - Repurchase of Common Stock | Research and development | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | 15,900 | ||||||||
Secondary Transaction - Repurchase of Common Stock | General and administrative | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | 16,500 | ||||||||
2022 Inducement Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Total shares of common stock reserved for issuance (in shares) | shares | 6,491,000 | 6,491,000 | 10,000,000 | ||||||
President | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | $ 3,200 | ||||||||
President | Share-Based Payment Arrangement, Tranche One | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Vesting percentage | 25% | ||||||||
President | Share-Based Payment Arrangement, Tranche Two | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Vesting percentage | 75% | ||||||||
ESPP | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Total shares of common stock reserved for issuance (in shares) | shares | 8,371,000 | 8,371,000 | |||||||
Offering period | 24 months | ||||||||
Number of purchase periods | purchasePeriod | 4 | ||||||||
Purchase period | 6 months | ||||||||
Share-based compensation arrangement by share-based payment award, weighted average price of shares purchased (in USD per share) | $ / shares | $ 13.33 | $ 13.33 | |||||||
Proceeds from issuance of common stock under employee stock purchase plan, net | $ 10,900 | ||||||||
ESPP offering period | 24 months | ||||||||
Share-based payment arrangement, expensed and capitalized, amount | $ 12,200 | 3,500 | |||||||
Stock options | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 4 years | ||||||||
Contractual term | 10 years | ||||||||
Stock options | President | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 4 years | ||||||||
Stock options | President | Inducement Plan And 2021 Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock options granted (in shares) | shares | 1,815,980 | ||||||||
Stock options | President | 2022 Inducement Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock options granted (in shares) | shares | 1,776,780 | ||||||||
Restricted Stock Units | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares approved for grant (in shares) | shares | 13,054,000 | ||||||||
Award vesting period | 4 years | ||||||||
Restricted stock units vested (in shares) | shares | 24,397,000 | ||||||||
Total grant date fair value | $ 235,000 | 51,300 | 0 | ||||||
Stock-based compensation expense | 173,400 | ||||||||
Restricted Stock Units | President | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 4 years | ||||||||
Restricted Stock Units | President | 2022 Inducement Plan | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares approved for grant (in shares) | shares | 1,732,501 | ||||||||
Performance Based Restricted Stock Units (PRSUs) | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock-based compensation expense | $ 27,600 | $ 9,000 | $ 0 | ||||||
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares approved for grant (in shares) | shares | 6,000,000 | 166,390 | |||||||
Total grant date fair value | $ 131,000 | ||||||||
Number of threshold stock price targets | target | 5 | ||||||||
Number of threshold vesting tranches | tranche | 5 | ||||||||
Trading day period | 60 days | ||||||||
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Minimum | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Threshold stock price target (in USD per share) | $ / shares | $ 70 | ||||||||
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Maximum | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Threshold stock price target (in USD per share) | $ / shares | $ 200 | ||||||||
Class A Common Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock, number of votes per share | vote | 1 | 1 | |||||||
Class A Common Stock | ESPP | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Purchase price of common stock in percent | 85% | ||||||||
Class B Common Stock | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Common stock, number of votes per share | vote | 10 | 10 | |||||||
Redeemable Convertible Series A Preferred Stock | Secondary transaction | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares issued and sold (in shares) | shares | 26,210 | ||||||||
Redeemable Convertible Series B Preferred Stock | Secondary transaction | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares issued and sold (in shares) | shares | 1,314,830 | ||||||||
Redeemable Convertible Series C Preferred Stock | Secondary transaction | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of shares issued and sold (in shares) | shares | 448,110 |
Stockholders' Equity and Stoc_4
Stockholders' Equity and Stock Based Compensation - Change in Unrealized Gains or Losses Within Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Change in Unrealized Gains or Losses Within Accumulated Other Comprehensive Income [Roll Forward] | |||
Beginning balance | $ 1,238,039 | $ (2,696,741) | $ (1,122,721) |
Net impact to other comprehensive (loss) income in current period | (6,684) | (1,158) | 272 |
Ending balance | 1,051,818 | 1,238,039 | (2,696,741) |
Accumulated Other Comprehensive Income | |||
Change in Unrealized Gains or Losses Within Accumulated Other Comprehensive Income [Roll Forward] | |||
Beginning balance | (747) | 411 | 139 |
Ending balance | (7,431) | (747) | 411 |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent | |||
Change in Unrealized Gains or Losses Within Accumulated Other Comprehensive Income [Roll Forward] | |||
Unrealized (losses) gains on available-for-sale debt securities | (6,684) | (1,152) | 405 |
Reclassification of unrealized gains to interest and other income, net, in the consolidated statements of operations | $ 0 | $ (6) | $ (133) |
Stockholders' Equity and Stoc_5
Stockholders' Equity and Stock Based Compensation - Shares of Common Stock Reserved for Future Issuance (Details) - shares | Dec. 31, 2022 | Aug. 31, 2022 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 102,051,000 | |
2021 Equity Incentive Plan: | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 52,178,000 | |
2022 Inducement Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 6,491,000 | 10,000,000 |
Share-Based Payment Arrangement | 2011 Stock Plan: | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 21,380,000 | |
Share-Based Payment Arrangement | 2022 Inducement Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 3,509,000 | |
Restricted Stock Units | 2021 Equity Incentive Plan: | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 10,122,000 | |
ESPP | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total shares of common stock reserved for issuance (in shares) | 8,371,000 |
Stockholders' Equity and Stoc_6
Stockholders' Equity and Stock Based Compensation - Fair Value Assumptions (Details) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Dividend yield | 0% | |
ESPP | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Dividend yield | 0% | 0% |
ESPP | Minimum | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected term (in years) | 6 months | 7 months 6 days |
Stock price volatility | 55.80% | 47.70% |
Risk-free interest rate | 1.54% | 0.06% |
ESPP | Maximum | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected term (in years) | 2 years | 2 years 1 month 6 days |
Stock price volatility | 84.50% | 58.50% |
Risk-free interest rate | 4.62% | 0.29% |
Stock options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected term (in years) | 6 years 1 month 6 days | |
Stock price volatility | 65% | |
Risk-free interest rate | 3.37% | |
Dividend yield | 0% | |
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected term (in years) | 7 years | |
Stock price volatility | 60% | |
Risk-free interest rate | 1.12% | |
Dividend yield | 0% |
Stockholders' Equity and Stoc_7
Stockholders' Equity and Stock Based Compensation - Summary of Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Number of Shares | |||
Beginning balance (in shares) | 1,348,000 | ||
Stock options granted (in shares) | 1,816,000 | 0 | 0 |
Stock options exercised (in shares) | (406,000) | ||
Stock options cancelled / forfeited / expired (in shares) | 0 | ||
Ending balance (in shares) | 2,758,000 | 1,348,000 | |
Options vested or expected to vest (in shares) | 2,758,000 | ||
Options exercisable (in shares) | 942,000 | ||
Weighted-Average Exercise Price | |||
Beginning balance (in USD per share) | $ 0.27 | ||
Stock options granted (in USD per share) | 13.61 | ||
Stock options exercised (in USD per share) | 0.27 | ||
Stock options cancelled / forfeited / expired (in USD per share) | 0 | ||
Ending balance (in USD per share) | 9.06 | $ 0.27 | |
Options vested or expected to vest (in USD per share) | 9.06 | ||
Options exercisable (in USD per share) | $ 0.27 | ||
Weighted-Average Remaining Contractual Term (in years) | |||
Weighted-Average Remaining Contractual Term (in years) | 7 years 3 months 18 days | 3 years 7 months 6 days | |
Options vested and expected to vest as of the end of the period | 7 years 3 months 18 days | ||
Options exercisable as of the end of the period | 2 years 8 months 12 days | ||
Aggregate Intrinsic Value | |||
Aggregate intrinsic value | $ 15,595 | $ 35,020 | |
Options vested or expected to vest as of the end of the period | 15,595 | ||
Options exercisable as of the end of the period | $ 13,598 |
Stockholders' Equity and Stoc_8
Stockholders' Equity and Stock Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units shares in Thousands | 12 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Number of Shares | |
Unvested, beginning balance (in shares) | shares | 47,830 |
Granted (in shares) | shares | 13,054 |
Vested (in shares) | shares | (24,397) |
Forfeited (in shares) | shares | (4,234) |
Unvested, ending balance (in shares) | shares | 32,253 |
Weighted-Average Grant Date Fair Value | |
Unvested, beginning balance (in USD per share) | $ / shares | $ 14.47 |
Granted (in USD per share) | $ / shares | 16.88 |
Vested (in USD per share) | $ / shares | 9.63 |
Forfeited (in USD per share) | $ / shares | 16.24 |
Unvested, ending balance (in USD per share) | $ / shares | $ 18.86 |
Stockholders' Equity and Stoc_9
Stockholders' Equity and Stock Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | $ 207,696 | $ 173,443 | $ 43,280 |
Stock-based compensation capitalized as internal-use software | 1,665 | 585 | 0 |
Total stock-based compensation expense | 209,361 | 174,028 | 43,280 |
President | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 3,200 | ||
Equity awards: | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 207,696 | 173,443 | 44 |
Secondary transaction | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 0 | 0 | 43,236 |
RSUs and PSUs | Chief Executive Officer | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 55,900 | 19,100 | |
Cost of revenue | Equity awards: | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 7,039 | 5,604 | 0 |
Research and development | Equity awards: | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 36,413 | 45,162 | 8 |
Sales and marketing | Equity awards: | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | 64,328 | 53,169 | 7 |
General and administrative | Equity awards: | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total employee awards | $ 99,916 | $ 69,508 | $ 29 |
Stockholders' Equity and Sto_10
Stockholders' Equity and Stock Based Compensation - Unrecognized Stock Based Compensation Expense (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Total unrecognized stock-based compensation expense | $ 558,122 |
RSUs and PSUs | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Stock-Based Compensation | $ 531,758 |
Weighted-Average Period to Recognize Expense (in years) | 3 years |
Stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Stock-Based Compensation | $ 13,758 |
Weighted-Average Period to Recognize Expense (in years) | 3 years 8 months 12 days |
ESPP | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Stock-Based Compensation | $ 12,606 |
Weighted-Average Period to Recognize Expense (in years) | 1 year 1 month 6 days |
Net Loss Per Share - Computatio
Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Numerator: | |||
Net loss | $ (232,132) | $ (191,995) | $ (57,294) |
Accretion of redeemable convertible preferred stock | 0 | (2,646,662) | (1,560,524) |
Net loss attributable to Class A and Class B common stockholders - basic | (232,132) | (2,838,657) | (1,617,818) |
Net loss attributable to Class A and Class B common stockholders - diluted | $ (232,132) | $ (2,838,657) | $ (1,617,818) |
Denominator: | |||
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares) | 284,587 | 130,652 | 76,945 |
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares) | 284,587 | 130,652 | 76,945 |
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share) | $ (0.82) | $ (21.73) | $ (21.03) |
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share) | $ (0.82) | $ (21.73) | $ (21.03) |
Net Loss Per Share - Potential
Net Loss Per Share - Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share (Details) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 35,135 | 49,338 | 189,962 |
Redeemable convertible preferred stock | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 0 | 0 | 153,938 |
RSUs and PSUs | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 32,253 | 47,830 | 33,928 |
Stock options | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 2,758 | 1,348 | 2,096 |
ESPP | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 124 | 160 | 0 |
Income Taxes - Net Loss Before
Income Taxes - Net Loss Before Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ (252,261) | $ (211,844) | $ (69,102) |
Foreign | 31,471 | 30,365 | 15,823 |
Loss before income taxes | $ (220,790) | $ (181,479) | $ (53,279) |
Income Taxes - Components of Pr
Income Taxes - Components of Provision for Income Tax (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Current: | |||
Domestic | $ 2,137 | $ 2,876 | $ (12) |
Foreign | 11,610 | 9,547 | 6,387 |
Deferred: | |||
Domestic | 0 | 0 | 0 |
Foreign | (2,405) | (1,907) | (2,360) |
Provision for income taxes | $ 11,342 | $ 10,516 | $ 4,015 |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of the federal statutory income tax rate to the Company’s effective tax rate (Details) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Federal income tax | 21% | 21% | 21% |
Stock-based compensation | (1.60%) | 2.10% | (17.10%) |
Change in valuation allowance | (22.40%) | (25.40%) | (11.80%) |
Earnings from foreign subsidiaries | (1.20%) | (0.50%) | (1.30%) |
Other items | (0.90%) | (3.00%) | 1.60% |
Total provision for income taxes | (5.10%) | (5.80%) | (7.60%) |
Income Taxes - Deferred Tax Ass
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred tax assets: | ||
Net operating loss carryforwards | $ 100,090 | $ 78,077 |
Foreign tax credit carryforwards | 4,955 | 4,955 |
Capitalized R&E under IRC 174 | 36,970 | 0 |
Stock-based compensation | 4,337 | 9,643 |
Accruals and Reserves | 9,032 | 6,584 |
Depreciation and amortization | 1,449 | 1,633 |
Allowance for uncollectible accounts | 212 | 66 |
Operating lease liability | 19,207 | |
Total deferred tax assets | 176,252 | 100,958 |
Less: valuation allowance | (146,134) | (89,903) |
Deferred tax assets, net of valuation allowance | 30,118 | 11,055 |
Deferred tax liabilities: | ||
Commissions | (6,146) | (4,771) |
Operating lease right-of-use assets | (15,283) | |
Net deferred tax assets | $ 8,689 | $ 6,284 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Examination [Line Items] | |||
Increase in valuation allowance | $ 56,200,000 | $ 48,800,000 | |
Gross unrecognized tax benefits | 3,647,000 | 2,227,000 | $ 0 |
Accrued interest | 800,000 | $ 500,000 | |
Domestic Tax Authority | |||
Income Tax Examination [Line Items] | |||
Net operating loss carryforwards | 429,600,000 | ||
Operating loss carryforwards subject to limitation | 10,700,000 | ||
State and Local Jurisdiction | |||
Income Tax Examination [Line Items] | |||
Net operating loss carryforwards | 151,400,000 | ||
Foreign Tax Authority | |||
Income Tax Examination [Line Items] | |||
Tax credit carryforward, amount | $ 5,000,000 |
Income Taxes - Schedule of Unre
Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ||
Unrecognized gross tax benefits at the beginning of the period | $ 2,227,000 | $ 0 |
Increases related to prior year tax positions | 0 | 1,269,000 |
Decreases related to prior year tax positions | (6,000) | 0 |
Increases in current year unrecognized benefits | 1,426,000 | 958,000 |
Unrecognized gross tax benefits at the end of the period | $ 3,647,000 | $ 2,227,000 |
Geographic Information - Schedu
Geographic Information - Schedule of Revenue and Long-Lived Assets by Geographical Region (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | $ 497,999 | $ 371,022 | $ 249,659 |
Total long-lived assets | 57,163 | 23,373 | |
North America | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 216,112 | 160,224 | 111,644 |
Total long-lived assets | 23,839 | 13,780 | |
Europe, Middle East and Africa | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 193,899 | 152,542 | 98,992 |
Total long-lived assets | 4,039 | 578 | |
Asia Pacific | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | 74,948 | 49,933 | 33,445 |
Total long-lived assets | 29,285 | 9,015 | |
Other | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenue | $ 13,040 | $ 8,323 | $ 5,578 |
Geographic Information - Narrat
Geographic Information - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 497,999 | $ 371,022 | $ 249,659 |
United States | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 192,200 | $ 142,900 | $ 99,200 |
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk, percentage | 39% | 39% | 40% |
United Kingdom | |||
Disaggregation of Revenue [Line Items] | |||
Revenue | $ 63,800 | $ 52,900 | $ 33,200 |
United Kingdom | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk, percentage | 13% | 14% | 13% |